A genome-wide regulatory network identifies key transcription factors for memory CD8+ T-cell development by Hu, Guangan & Chen, Jianzhu
 1 
 
A Genome-wide Regulatory Network Identifies Key Transcription 
Factors for Memory CD8+ T Cell Development 
 
Guangan Hu and Jianzhu Chen 
 
David H. Koch Institute for Integrative Cancer Research and Department of Biology, 
Massachusetts Institute of Technology, Cambridge, MA 02139, USA 
 
Corresponding to Jianzhu Chen (jchen@mit.edu) 
 
 
Author’s contacts: 
 Guangan Hu (gahu@mit.edu) 
 Jianzhu Chen (jchen@mit.edu) 
 
  
 2 
Abstract 
Memory CD8+ T cell development is defined by the expression of a specific set of memory 
signature genes (MSGs). Despite recent progress, many components of the transcriptional 
control of memory CD8+ T cell development are still unknown. To identify transcription factors 
(TFs) and their interactions in memory CD8+ T cell development, we construct a genome-wide 
regulatory network and apply it to identify key TFs that regulate MSGs. Most of the known TFs 
in memory CD8+ T cell development are rediscovered and about a dozen new TFs are also 
identified. Sox4, Bhlhe40, Bach2 and Runx2 are experimentally verified and Bach2 is further 
shown to promote both development and recall proliferation of memory CD8+ T cells through 
Prdm1 and Id3. Gene perturbation study identifies the mode of interactions among the TFs with 
Sox4 as a hub. The identified TFs and insights into their interactions should facilitate further 
dissection of molecular mechanisms underlying memory CD8+ T cell development. 
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Immunological memory refers to faster and stronger responses to re-encountering of the same 
antigen. The basis for this enhanced response is the persistence of more abundant and 
intrinsically more reactive antigen-specific memory T and B lymphocytes that are generated 
following the initial antigen stimulation. Memory CD8+ T cells are usually generated following 
antigen-stimulated T cell activation and expansion. In a typical CD8+ T cell response, naïve 
CD8+ T cells are activated to undergo clonal expansion when stimulated by appropriate antigen 
1.  The resulting T cells acquire effector functions and migratory properties that allow them to 
clear antigens in both lymphoid and non-lymphoid organs. As antigen is cleared, most of the 
effector T cells die by apoptosis and only a small fraction survive and differentiate into memory 
CD8+ T cells. Memory CD8+ T cells are often divided into two subsets. Effector memory T cells 
(TEM) are CD62LloCCR7lo and capable of rapid expression of effector functions following 
antigen stimulation to confer faster memory response.  Central memory T cells (TCM) are 
CD62LhiCCR7hi and proliferate extensively upon antigen restimulation to confer stronger 
memory response.  
 
Memory CD8+ T cells are developmentally programmed as they express a specific set of 
memory signature genes (MSGs) 2, 3, which confer them with characteristic memory phenotype 
and function. Like many developmental processes, memory CD8+ T cell development is 
ultimately controlled by transcription factors (TFs) that integrate external and internal signals to 
regulate the expression of the MSGs. In recent years, several studies have shed light on TFs that 
regulate the development of memory CD8+ T cells. T-bet (encoded by Tbx21) and 
Eomesodermin (encoded by Eomes), both member of the T-box family, are essential for the 
differentiation of effector and memory CD8+ T cells 4, 5, 6. Tcf7 is a TF downstream of the Wnt 
signaling. Consistent with the observation that activation of Wnt/!-catenin signaling promotes 
memory CD8+ T cell development by suppressing terminal differentiation of effector T cells 7, 8, 
Tcf7-deficiency in CD8+ T cells impairs TCM differentiation 9.  Klf2 has been shown to be 
associated with memory CD8+ T cell development 10 probably by directly controlling the 
expression of cell surface receptors S1P1 and CD62L 11, 12. Id2 and Id3, the E-box-containing 
transcription suppressors, appear to regulate the development of memory CD8+ T cell subsets 13. 
Id2-knockout mice are deficient in memory CD8+ T cells, but effector T cells generated in these 
mice are CD127hiCD62Lhi, a phenotype similar to TCM14. Deficiency in Id3 inhibits, whereas 
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overexpression of Id3 promotes memory CD8+ T cell development 15. The B-cell transcriptional 
repressor Blimp-1 (encoded by Prdm1) promotes the terminal differentiation of effector CD8+ T 
cells and is required for recall response of memory T cells 16, 17. Despite these progresses, the 
current understanding of transcriptional regulation of memory CD8+ T cell development is still 
limited, as additional TFs as well as their coordination are likely required to respond to external 
and internal signals in order to establish the MSG program for memory CD8+ T cell 
development.  
  
In this study, we assemble a genome-wide regulatory network associated with the development 
of CD8+ T cells using publicly available gene expression data and a reverse-engineering 
algorithm. This regulatory network is applied to identify key TFs that regulate memory CD8+ T 
cell development using the master regulator analysis (MRA) of the MSGs of CD8+ T cells.  The 
inferred TFs include most of the known TFs as well as a dozen new TFs with limited functional 
information in CD8+ T cell differentiation. A regulatory module controlling the MSGs is 
constructed and the high accuracy of the regulations in the module is verified using ChIP-PCR. 
Gene perturbations identify multiple regulatory motifs among the key TFs, suggesting their 
complex regulations during the memory CD8+ T cell development. Four of the newly identified 
key TFs (Sox4, Bhlhe40, Bach2, and Runx2) are experimentally validated to regulate memory 
CD8+ T cell development and function. Bach2 is shown to promote memory CD8+ T cell 
development and recall proliferation through Id3 and Prdm1. Our study represents the most 
comprehensive analysis of TFs and their interactions in memory CD8+ T cell development to 
date. The identified TFs and the insights into their mode of interactions provide a foundation for 
further dissecting the molecular mechanisms underlying memory CD8+ T cell development. 
 
Results 
Identification of TFs associated with memory CD8+ T cells  
We collected 386 gene expression profiles of naïve, effector and memory CD8+ T cells of the 
mouse from 35 independent GEO datasets (Supplementary Table S1). 1,445 genes coding 
putative TFs 18 were manually mapped to the latest mouse genome to eliminate redundant and 
erroneous annotations, resulting in a total of 1,038 putative TFs. Among these putative TFs, 464 
were expressed during the naïve to effector to memory CD8+ T cell development (see Methods 
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for detail). Using a reverse-engineering algorithm CLR (context likelihood of relatedness)19, the 
386 gene expression profiles and the 1,038 putative TFs, a genome-wide regulatory network was 
assembled.  The network consisted of 107,157 interactions among 11,032 genes. 62,272 
interactions (58%) were between the 276 of the 464 expressed putative TFs and 8,572 target 
genes, suggesting that interactions are enriched among the expressed genes (P<0.001, binomial 
test). Furthermore, 3,219 of these interactions involve 154 out of 196 (79%) identified MSGs 3 
(Supplementary Fig. S1).  
 To identify key TFs that regulate MSGs, we applied the MRA to the CLR-inferred 
interactions (Fig. 1a, see Methods). The MRA algorithm computes the statistical significance of 
overlaps of all interactions of each TF (inferred by CLR) with MSGs or a control gene set by a 
binomial test. From the 1,038 putative TFs, MRA identified 60 MSG-specific TFs at P<0.05 
(binomial test), all of which are expressed in CD8+ T cells (Supplementary Table S2). These 60 
candidates were filtered by removing those whose knockout do not have any immune system 
phenotype as defined in MGI (Mouse Genome Informatics) 20. The positive candidates were then 
analyzed for enrichment of DNA-binding motifs among MSGs or differential expression among 
naïve, effector and memory CD8+ T cells (see Methods). This led to 21 key TFs that were ranked 
according to the numbers of MSG they regulate (Table 1). Text-mining of public references on 
these 21 TFs revealed that 8 of 12 known TFs, which have been reported to be involved in 
memory CD8+ T cell development and function 21, 22, 23, 24, were identified by our analysis. These 
results show that our systematic approach is valid for identifying TFs that regulate memory 
CD8+ T cell development. 
 
Validation of a regulatory module for memory signature genes 
To further explore the relative importance of the 21 identified TFs in regulating MSGs, we 
constructed a regulatory module using the top 10-ranked TFs (Fig. 1b). The resulting module 
contained 56% (86 out of 154) of MSGs that were present in the entire network (Supplementary 
Fig. S1). To verify this regulatory module, chromatin immunoprecipitation (ChIP) was 
performed for the top 3 TFs, Sox4, Tcf7 and Eomes, in CD8+ T cells followed by PCR 
amplification of promoter regions (within 1 kb upstream of the transcription-starting site) of 
randomly selected MSGs that were predicted to be regulated by Sox4 or Tcf7 or Eomes. As 
shown in Fig. 1c and 1d, promoter regions of 10 out of the 12 randomly selected Sox4-regulated 
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MSGs were amplified. Similarly, 12 out of 14 randomly selected Tcf7-regulated MSGs and 6 out 
of 9 randomly selected Eomes-regulated MSGs were amplified. On average, 80% of the tested 
promoter regions were immunoprecipitated with antibodies specific for each of the three TFs 
(Table 2), confirming the high accuracy of the constructed regulatory module. Furthermore, 
when the cumulative coverage of MSGs was plotted as a function of each of the 21 TFs, the top 
2 TFs, Sox4 and Tcf7, were shown to regulate 42% of MSGs (Supplementary Fig. S2). 
 
Perturbation network of key TFs  
Although the constructed regulatory module predicts interactions between TFs (Fig. 1b), the 
directions of regulation are not known. To find out these, the top 10 TFs and another two known 
memory-regulating TFs (Id3 and Tbx21, #12 and #19 in the list, Table 1) 6, 15, 25 were perturbed 
in CD8+ T cells in vitro by overexpression through retroviral transduction. The transcript level of 
each of the 12-selected TFs was measured by quantitative real-time PCR (Table 3). If changes in 
transcript level of "2 fold were taken as directional regulations, the perturbation results identified 
41 regulations among the 12x12 matrix (31%).  Notably, the top 3 TFs (Sox4, Tcf7 and Eomes) 
directed 19 of the 41 regulations. To verify these regulations, ChIP-PCR was performed using 
antibodies specific for Sox4, Tcf7 and Eomes. As shown in Fig. 2a, 18 of the 19 regulations were 
confirmed. ChIP-PCR also identified 4 more regulations that were not observed in the 
perturbation study. Thus, compared to ChIP-PCR, perturbation studies is able to identify the 
directional regulations with 82% sensitivity and 91% specificity.  
 We then constructed a perturbation network of the 12 TFs with directional regulations 
(Fig. 2b). The top 3 TFs (Sox4, Tcf7 and Eomes) and Bach2 had more downstream targets than 
the number of TFs that regulate them (Supplementary Fig. S3), suggesting that they are at the 
upstream of a regulatory structure. TFs in the perturbation network formed multiple motifs, such 
as feedback and feed-forward loops (Supplementary Fig. S4). For example, in a feedback motif 
of Sox4-Tcf7-Eomes-Tbx21 (Fig. 2c), Sox4 and Tcf7 regulate each other and they also regulate 
expression of Eomes and/or Tbx21.  The latter regulations were further confirmed at the protein 
level as indicated by suppression of Eomes and Tbx21 by overexpression of Sox4 or Tcf7 
(Supplementary Fig. S5). These results suggest that complex regulations involving multiple 
regulatory motifs among these TFs are involved in memory CD8+ T cell development.  
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Validation of Sox4 and Bach2 in memory CD8+ T cells  
Among the top 10 TFs (Table 1), 6 are known to play important roles in memory CD8+ T cell 
development and/or function. We then investigated whether the other 4 TFs (Sox4, Bhlhe40, 
Bach2 and Runx2) are also involved in memory CD8+ T cell development/function by examining 
the effect of overexpression and knockdown of these TFs on the recall proliferation of memory 
CD8+ T cells in vitro and in vivo. CD8+ T cells expressing the 2C TCR were activated with 
cognate peptide SIYRYYGL (SIY) and then transduced with retroviruses expressing GFP plus 
Sox4, Bhlhe40, Bach2 or Runx2 or expressing GFP plus shRNA specific for one of the four TFs 
(Supplementary Table S3 and S4). The 2C T cells were then cultured in the presence of cytokine 
IL-7 to induce the development of memory CD8+ T cells (Supplementary Fig. S6). To assay 
recall proliferation, the in vitro memory 2C T cells were restimulated with SIY and the number 
of transduced (GFP+) and non-transduced (GFP-) 2C T cells were quantified on day 4 and 6. 
Compared to the vector control, overexpression of Sox4 or Bach2 led to a significant increase in 
the proportions of GFP+ cells (Fig. 3a), suggesting a higher recall proliferation. When the in vitro 
generated memory 2C T cells were adoptively transferred into C57BL/6 (B6) mice followed by 
activation through infection with influenza virus that express SIY (WSN-SIY virus) 26, a 
significant increase in the proportion of GFP+ 2C T cells was also observed in the draining 
lymph nodes (DLN) (Fig. 3b), the blood, lung and spleen (Supplementary Fig. S7) 5 days post 
infection (dpi) if the transduced memory T cells expressed Sox4 or Bach2. Conversely, 
knockdown of Sox4 or Bach2 (Supplementary Fig. S8) resulted in a significant inhibition of the 
recall proliferation of memory 2C T cells both in vitro and in vivo (Fig. 3c,d). Although 
overexpression of Bhlhe40 and Runx2 inhibited the in vivo recall proliferation of the transduced 
memory 2C T cells (Fig. 3b), no significant change was observed in in vitro recall response (Fig. 
3a) and in knockdown assay (Fig. 3c,d). As positive controls, we tested in parallel known TFs: 
overexpression of Eomes promoted the recall proliferation whereas overexpression of Klf2 
inhibited the recall proliferation (Supplementary Fig. S9), consistent with previous reports 9, 11. 
These results show that Sox4 and Bach2 likely promote the recall proliferation of memory CD8+ 
T cells.  
 
Enhanced memory T cell development by Bach2 overexpression  
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To confirm the effect of overexpression of Bach2 on recall proliferation of memory CD8+ T cells, 
we activated 2C T cells in vitro for two days, transduced the activated T cells with retroviruses 
expressing GFP alone or GFP plus Bach2.  The cells were cultured in the presence of IL-2 for 
two more days and then adoptively transferred into antigen-free B6 mice to induce in vivo 
memory 2C T cells (Fig. 4a).  Twenty-three days after transfer, the frequency, phenotype and 
function of persisting 2C T cells were analyzed. Both transduced (GFP+) and non-transduced 
(GFP-) 2C cells persisted in the recipient mice (Fig. 4b), GFP+ 2C cells exhibited a typical 
memory phenotype as indicated by expression of CD62L and IL-7 receptor (IL-7R), similar to 
the GFP- 2C cells in the same recipient (Fig. 4c). The persisting memory 2C cells, both 
transduced and non-transduced, were rapidly induced to express IFN! and TNF" following 
antigen stimulation (Fig. 4d). Furthermore, some recipient mice were infected with WSN-SIY 
virus and the recall proliferation of persisting 2C cells in the spleen and DLN were analyzed 7 
days later. As shown in Fig. 4e, if the 2C cells were originally transduced with GFP-expressing 
retrovirus, the proportion of GFP+ versus GFP- 2C cells did not changed following WSN-SIY 
challenge. However, if the 2C cells were originally transduced with GFP and Bach2-expressing 
retrovirus, the proportion of GFP+ cells was significantly higher in both DLN and spleen, 
suggesting a stronger recall proliferation by Bach2-expressing memory 2C cells.  
 
The observed stronger recall response by Bach2-expressing memory 2C cells could be due to the 
generation of more memory T cells and/or that the Bach2-expressing memory T cells are more 
responsive to restimulation.  To investigate these possibilities, we activated 2C T cells in vitro 
for two days and transduced them with retroviruses expressing GFP alone (vector) or GFP plus 
Bach2 (Fig. 5a). Twenty-four hours later, the T cells were adoptively transferred into B6 mice 
followed by WSN-SIY virus infection. 2C T cell responses were analyzed by flow cytometry 7 
dpi. Compared to the non-transduced 2C T cells, vector-transduced 2C T cells had the same 
expression profiles for CD62L, IL-7R, Klrg1 and CD27 in the same organs of the same mice 
(Fig. 5b, upper panel). In contrast, a significantly higher proportion of Bach2-transduced 2C T 
cells expressed CD62L and CD27, but a significantly lower fraction expressed Klrg1, in the 
DLN and spleen compared to non-transduced 2C cells in the same organs of the same recipients. 
When the persisting 2C T cells were analyzed 30 dpi, no significant differences in IFN! and IL-2 
expression were observed among non-transduced, vector-transduced and Bach2-transduced 2C T 
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cells in response to restimulation in vitro (Fig. 5c and Supplementary Fig. S10).  Although no 
difference in CD62L and IL-7R expression was detected, CD27 was higher in Bach2-transduced 
than vector-transduced 2C T cells in the lung and DLN. (Fig. 5c and Supplementary Fig. S10). 
Importantly, significantly more Bach2-transduced 2C T cells persisted in the DLN, spleen and 
bone marrow (Fig. 5d,e). These result suggest that overexpression of Bach2 likely promotes the 
generation of memory CD8+ T cells in vivo. 
 
We further investigated the effect of Bach2 overexpression in naïve 2C T cells on memory CD8+ 
T cell development in vivo. Bone marrow progenitor cells isolated from 2C TCR transgenic mice 
were transduced with retroviruses expressing GFP alone or GFP plus Bach2 and adoptively 
transferred into sublethally irradiated Rag2-/- mice to generate naïve 2C T cells that express GFP 
or GFP plus Bach2 (Fig. 6a). The resulting transduced and non-transduced naïve 2C cells were 
then adoptively transferred into B6 mice followed by infection with WSN-SIY virus. The 
frequency, phenotype and function of 2C T cells were analyzed 7 dpi. Vector-transduced and 
non-transduced 2C T cells from the same recipient mice had the same expression profile of 
CD62L, IL-7R, Klrg1, IFN! and TNF" (Fig. 6b). While Bach2-transduced 2C T cells expressed 
similar levels of IFN! and TNF" as non-transduced and vector-transduced 2C T cells, more cells 
expressed CD62L but fewer cells expressed Klrg1, resembling to CD62LhiKlrg1low memory 
precursors (Fig. 6b and Supplementary Fig. S11). By 30 dpi, no significant differences were 
observed among non-transduced, vector-transduced and Bach2-transduced 2C T cells in 
expression of CD62L, IL-7R, Klrg1, IFN! and TNF" (Fig. 6c). However, more Bach2-
transduced 2C T cells were found in the blood, lung, DLN and spleen 30 dpi (Fig. 6d,e). 
Together, these data suggest that overexpression of Bach2 promotes the development of memory 
CD8+ T cells.  
 
Diminished memory T cell development due to Bach2 deficiency 
We also examined the effect of Bach2 knockdown on memory T cell development. The approach 
was the same as outlined as in Figure 5a, except the retrovirus expressed shRNA specific for 
Bach2. Briefly, activated 2C T cells were transduced with shRNA-expressing retrovirus and 
adoptively transferred into B6 mice followed by infection with WSN-SIY influenza virus. The 
number and frequency of GFP+ and GFP- 2C T cells in various organs were analyzed 7 and 30 
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dpi. No significant difference was observed among non-transduced, vector-transduced and 
shRNA-transduced 2C T cells in terms of CD62L, IL-7R, Klrg1, CD27 and IFN! expression 
(Supplemental Fig. S12). However, the proportion of shRNA-transduced 2C T cells was reduced 
significantly in the blood, lung, DLN, spleen and bone marrow 30 but not 7 dpi (Fig. 5f). 
Consistently, the number of shRNA-transduced 2C T cells in the spleen was lower as compared 
to the numbers of non-transduced and vector-transduced 2C T cells 30 dpi (Supplemental Fig. 
S12c).  
 
To investigate the effect of Bach2 knockout on memory T cell development, we constructed 
chimeric mice where T and B cells were deficient in Bach2 by adoptively transferring bone 
marrow cells from Bach2 knockout mice into sublethally irradiated Rag2-/- mice. Three months 
after reconstitution, mice were infected with WSN-SIY influenza virus and analyzed for the 
presence of SIY-specific memory CD8+ T cells 30 days later. The percentage of SIY-specific 
CD8+ T cells was lower in the DLN and spleen of chimeric mice that were reconstituted with 
Bach2-/- than Bach2+/+ bone marrow cells (Fig. 5g). Consistently, the number of SIY-specific 
CD8+ T cells in the spleen was lower in mice reconstituted with Bach2-/- than Bach2+/+ bone 
marrow cells.  Considering that Bach2 expression was down-regulated in effector and then up-
regulated in memory T cells during naïve to effector to memory cell transition (Table 1), together 
these results show that Bach2 promotes memory CD8+ T cell development.   
 
Enhanced proliferation of T cells by Bach2 overexpression  
To further explore the mechanism underlying the observed effect of Bach2 on memory T cell 
development and response, we examined whether Bach2 affects T cell proliferation. 2C T cells 
were activated in vitro and transduced with either vector or Bach2-expressing retroviruses. The 
cells were cultured in the presence of either IL-2 or IL-7 and the proportion of transduced (GFP+) 
versus non-transduced (GFP-) cells in the same cultures was quantified over time. In the IL-7 
culture, the proportion of transduced versus non-transduced 2C cells remained stable regardless 
whether the 2C T cells were transduced with vector or Bach2 (Fig. 7a). Similarly, the proportion 
of vector-transduced versus non-transduced 2C cells remained stable in the IL-2 cultures. 
However, the proportion of Bach2-transduced 2C T cells increased significantly over time in the 
IL-2 cultures (Fig. 7a). When the cells were lableled with eFluor and followed over time, Bach2-
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transduced 2C T cells diluted the flourescent dye more extensively than non-transduced 2C T 
cells (Fig. 7b). These data suggest that Bach2 promotes proliferation of activated CD8+ T cells. 
 
We noticed a feed-forward regulatory motif of Sox4-Bach2-Prdm1-Id3 in the perturbation 
network (Fig. 7c and Supplementary Fig. S4). We verified this regulatory motif by showing that 
overexpression of Bach2 suppressed expression of Prdm1 but stimulated expression of Id3 at 
transcriptional (Table 3) and translational levels (Fig. 7d). ChIP-PCR analysis with anti-Bach2 
antibody also confirmed that Bach2 binds directly to the promoter regions of Prdm1 and Id3 (Fig. 
7e, f). Further supporting the regulatory motif, overexpression of Prdm1 significantly reduced 
the Bach2-mediated proliferation of activated T cells (Supplementary Fig. S13). As Prdm1 is 
known to inhibit T cell proliferation whereas Id3 stimulates survival of effector T cells 15, 16, we 
determined the effect of Bach2 overexpression on molecules that regulate cell cycle and survival. 
Overexpression of Bach2 stimulated CDK4, CDK6 and Bcl6 expression and Rb phosphorylation 
at amino acid residues 780 and 795 but inhibited expression of p27kip (Fig. 7g). These results 
suggest that Bach2 regulates memory T cell development and recall proliferation by regulating 
cell cycle control possibly through Prdm1 and Id3.  
 
Discussion 
At the molecular level, development of memory CD8+ T cells is the establishment of MSG 
expression program, which ultimately is controlled by TFs. Although several TFs have been 
described to regulate memory CD8+ T cell development, for a comprehensive understanding of 
transcriptional regulation of memory CD8+ T cell development, it is necessary to identify most, 
if not all, key TFs that regulate MSGs and construct a genome-wide transcriptional network that 
supports memory CD8+ T cell development. Using systems biology approaches and publically 
available gene expression data, here we have assembled a genome-wide regulatory network 
associated with CD8+ T cells of the mouse. Applying MRA to this network, we have identified 
twenty-one key TFs, down-narrowed from 1038 putative TFs, which regulate the expression of 
70% of MSGs. Our approach is valid based on the following considerations. First, our method 
identified eight of the twelve TFs known to be involved in memory CD8+ T cell development, 
including Tcf7, Eomes, Prdm1, Klf2, Id2, Stat4, Id3 and Tbx21 (Table 1). Although Bcl6, Stat3 
and Myc are known to regulate memory CD8+ T cell development, they were not within the top 
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21 TFs identified using our methodology because CLR-inferred targets do not overlap with 
MSGs possibly due to limited data on MSGs or the network. NF-!b plays important roles in both 
effector and memory T cell development 27, 28. We found that NF-!b was a key TF that regulates 
effector signature genes (ESG) when MRA was applied to the network and ESGs. Second, our 
method identified several TFs that are not known to function in the memory CD8+ T cell 
development, including Sox4, Bhlhe40, Bach2 and Runx2 in the top 10 TFs (Table 1). Follow-up 
experimentation showed that these newly identified TFs indeed play important roles in memory 
CD8+ T cell development and function.  Overexpression of Sox4 and Bach2 promoted a 
significantly higher recall proliferation of memory CD8+ T cells both in vitro and in vivo. 
Conversely knockdown of Sox4 and Bach2 inhibited the recall proliferation of the transduced 
memory T cells (Fig. 3). Overexpression of Bhlhe40 and Runx2 inhibited the in vivo recall 
proliferation, although no significant change was observed in in vitro recall response and in 
knockdown assay (Fig. 3). Further analysis showed that overexpression of Bach2 also promotes 
memory CD8+ T cell development (Fig. 4-6). Third, compared to the traditional method of 
differential gene expression analysis 2, 3, which generates a long list of candidates using fold-
change-based approaches, our network methods identify and rank order TFs according to their 
statistical importance. Reduction of hundreds of TFs to two-dozen key TFs makes direct 
experimental validation more manageable. The network approach and methodologies developed 
here can be applied to any phenotypic transition, such as effector T cells and exhausted T cells, 
to identify novel transcriptional modules and TFs.  
 
Studies have suggested that memory CD8+ T cell development is coordinately regulated by 
several TFs (reviewed in Refs. 22, 24), including Eomes and Tbx21 4.  Our network and 
perturbation studies have now greatly expanded the understanding of the mode of interactions to 
the top 21 TFs. Our analysis reveals a dense overlapping regulation (DOR) among the key TFs 
(Fig. 2b). This mode of regulation is essential for sensing multiple external signals and integrate 
them into distinct cell fate outcomes 29.  As two classes of TFs have been proposed to control the 
developmental potentials of effector and memory fates in a quantitative manner 22, 24, 30, the DOR 
might contribute to the quantitative regulations during effector to memory CD8+ T cell 
development. Our analysis also shows complex regulations with both feedback and feed-forward 
motifs among the key TFs (Table 3 and Fig. 2b). In the regulatory motif of Sox4-Tcf7-Eomes-
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Tbx21, Tcf7, Eomes and Tbx21 are known to be critical for memory CD8+ T cell development. 
The association of Sox4 with these three TFs and especially its “hub” position in this motif are 
intriguing. Sox4 is not known to regulate memory CD8+ T cell development. However, it 
stabilizes !-catenin to modulate Wnt-Tcf7 signaling 31, 32, which promotes memory CD8+ T cell 
development. Sox4 also regulates ‘stemness’ of cancer cells 33, a property shared by memory T 
cells. Furthermore, evidence suggests that Sox4 might be a direct regulatory target of TGF! 
signaling 34, which is essential for the differentiation of CD8+ T cells 35. These previous 
observations, together with our finding of the “hub” position of Sox4 in the regulatory motif of 
Sox4-Tcf7-Eomes-Tbx21, suggest that Sox4 is a critical TFs regulating memory CD8+ T cell 
development. While this hypothesis has yet to be validated, our finding that overexpression of 
Sox4 promotes recall proliferation of memory T cells suggests that Sox4 is involved in memory 
CD8+ T cell development.  
 
In the regulatory motif of Sox4-Tcf7-Eomes-Tbx21, we found that Tcf7 binds to Eomes promoter 
(Fig. 2a) and retroviral expression of Tcf7 leads to a downregulation of Eomes transcript (Table 
3) and protein (Supplementary Fig. S5). The latter results contradict with the previous report 
showing that the level of Eomes transcript and protein are decreased in memory CD8+ T cells 
from Tcf7-deficient mice 9. Although we do not know the precise causes underlying the observed 
opposite effects, the following differences between the two studies may provide part of the 
explanation. First, our study was carried out in in vitro, using activated CD8+ T cells that are in 
transition to memory T cells, whereas the previous study used memory CD8+ T cells directly 
from mice. Second, in our study, we overexpressed Tcf7 for a short period (72 hrs) before 
assaying the effect on Eomes expression, whereas the previous study examined the accumulated 
effect of germline Tcf7 knockout on Eomes expression. The differences in the stage of T cells, in 
vitro vs. in vivo, overexpression vs. deficiency, and the length of Tcf7 overexpression or 
deficiency could all contribute to the observed differences in the two studies. Although the 
discrepancy raises concern of our approach, results from our perturbation study on the effect of 
Bach2 on Prdm1, Prdm1 on Tcf7, and Id2 on Id3 are all consistent with previous reports 17, 36, 37, 
suggesting the validity of our in vitro assay in most cases.  
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Our detailed analysis of the feed-forward motif of Sox4-Bach2-Prdm1-Id3 (Fig. 7c) reveals new 
insight into memory CD8+ T cell development.  This regulatory motif includes two known TFs 
(Id3 and Prdm1) and two unknown TFs (Sox4 and Bach2) in memory CD8+ T cell development. 
Through both overexpression and knockdown/knockout in CD8+ T cells both in vitro and in mice, 
we provide extensive evidence showing that Bach2 promotes memory CD8+ T cell development 
(Fig. 4-6). One mechanism appears to be by stimulating the induction of memory T cell 
precursors as Bach2-expression in effector T cells leads to a phenotype of CD62LhiKlrgloCD27+ 
(Fig. 5b-c and Supplementary Fig. S10), which is considered as central memory T cell precursors 
with high proliferative potential 38, 39. Recently, two studies report that Bach2 regulates CD4+ T 
cell development and function by suppressing effector gene expression 40, 41. Our observation 
that Klrg1 is suppressed by Bach2 suggests that suppression of effector function may also be 
important for the development of memory CD8+ T cells. Another mechanism is by stimulating T 
cell proliferation. We showed that overexpression of Bach2 enhances IL-2 driven T cell 
proliferation in vitro and recall proliferation in vitro and in vivo. In addition, when in vitro 
memory 2C T cells were labeled with eFluro dye and adoptively transferred into Rag-/- mice, 
Bach2-transduced T cells diluted the flourescent dye more extensively than the non-transduced 
and vector-transduced T cells (Supplemental Fig. S14). The enhanced proliferation could lead to 
development and/or survival of memory T cells.  
 
Our study further sheds light on the mechanisms by which Bach2 promotes T cell proliferation. 
In the regulatory motif, Bach2 promotes Id3 expression but suppresses Prdm1 expression 
through direct binding to their promoter regions (Fig. 7c-f), the latter is consistent with Bach2 
suppression of Prdm1 expression in B cells 37. Id3 is known to promote cell cycle and recall 
proliferation of memory CD8+ T cells by binding to and inhibiting E proteins 15, 42. Thus, by 
promoting Id3 expression, Bach2 stimulates T cell proliferation.  Prdm1 is known to antagonize 
Bcl6, which promotes cell cycle by suppressing the expression of cell cycle inhibitor p27kip 43. 
Bcl6-/- mice exhibit a profound deficiency of memory T cells 44, 45, whereas in the absence of 
p27kip, memory CD8+ T cells exhibit enhanced homeostatic and recall proliferation 46. 
Consistently, we show that overexpression of Bach2 promotes Bcl6 expression but inhibits 
p27kip expression (Fig. 7g). Thus, Bach2 also stimulates T cell proliferation by suppressing 
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Prdm1 expression.  Together, these findings suggest that Bach2 promotes memory CD8+ T cell 
development and recall proliferation through Id3- and Prdm1-mediated cell cycle control.  
 
Development of memory CD8+ T cells requires integration of multiple external and internal 
signals to establish a new transcriptional program of MSGs that endows memory CD8+ T cells 
with characteristic features in phenotype, tissue distribution, homeostasis and recall potentials. In 
this study, we have shown that integrated systems biology approaches can be effectively used to 
identify key TFs and their mode of interactions that underlies memory CD8+ T cell 
differentiation and function. Further analysis of motifs in the regulatory network should help to 
elucidate in detail the molecular mechanisms underlying memory CD8+ T cell development and 
function.  
 
Methods 
Regulatory network and master regulator analysis  
386 public microarrays related to CD8+ T cells from 35 independent GEO datasets (till 
September 2009) were downloaded from the NCBI database of Gene Expression Omnibus 
(GEO) (Supplementary Table S1). All raw image files were reprocessed to normalize the data 
using R program with a gcRMA method. Gene expression data was used to construct the 
regulatory network with the putative TFs using a reverse engineering algorithm CLR 19. Among 
the 1,445 putative TFs identified according to the domain predictions of protein sequences 18, 
1,038 were manually mapped to the latest mouse genome.  To compare gene expression in 
different CD8+ T cells, samples were grouped into naïve, effector and memory based the cell 
types from which the microarray analysis were done (Supplementary Table S1). Gene was 
considered as expressed in CD8+ T cells if the average gene expression level in one of the three 
groups was more than 8 (gcRMA values).  
 To identify TFs associated with memory CD8+ T cell development, we used Master 
Regulator Analysis (MRA) to compute the statistical significance of overlaps of all interactions 
of each TF (inferred by CLR) with MSGs or a control gene set by a binomial test. The MSGs 
were differentially expressed genes between memory CD8+ T cells and naïve/effector CD8+ T 
cells identified previously 3. 332 background genes were identified from the 386 gene expression 
profiles based on high levels of gene expression (gcRMA value >10) but minimal variation 
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among 386 samples (variation from mean <0.5). This criterion minimizes the potential of the 
selected genes not being regulated by TFs in CD8+ T cells. From the 1,038 putative TFs, MRA 
identified 60 MSG-specific TFs at P<0.05 (binomial test), all of which are expressed in CD8+ T 
cells (Supplementary Table S2). These 60 candidates were filtered by removing those whose 
knockout does not have any immune system phenotype as defined in MGI 20. The positive 
candidates were analyzed for enrichment of DNA-binding motifs in the promoter regions (-2000 
to -1) of the MSGs using the program MatInspector 47 or differential expression among naïve, 
effector and memory CD8+ T cells. This led to 21 key TFs that exhibit immune system 
phenotype with either an enrichment of DNA-binding motifs among MSGs or differential 
expression. 
 
Mice and virus  
The 2C TCR transgenic mice on Rag2-/- and C57BL/6 (B6 Thy1.1+) background (2C+Rag-/-) 
were maintained in the animal facility at the Massachusetts Institute of Technology (MIT). These 
mice express the 2C TCR on CD8+ T cells specific for SIYRYYGL peptide (SIY) in association 
with MHC class I Kb molecule 48. B6 and Rag2-/- mice were from the Jackson Laboratory. Mice 
were used at 8-16 weeks of age. All animal studies and procedures were approved by the 
Massachusetts Institute of Technology’s Committee for Animal Care. Recombinant WSN-SIY 
virus encoding the SIY epitope in the neuroaminidase stalk was constructed by plasmid-based 
reverse genetics and grown in Madin-Darby canine kidney cells 26. For infection, mice were 
anesthetized and given 100 pfu (sublethal dose) intranasally.  
 
Flow cytometry and cell sorting 
Antibodies specific for CD8", Thy1.1, Klrg1, CD62L, CD127 (IL-7R), CD27, IFN!, TNF", IL-
2, Eomes and T-bet (Tbx21) were purchased from BioLegend or eBiosciences and used at the 
recommended concentration. Single cell suspensions were prepared from spleens and 
mediastinal (draining) lymph nodes (DLN), peripheral blood, and lung. Splenocytes and 
lymphocytes were collected in 8 ml HBSS by crushing the spleen and lymph node with frosted 
glass slides and filtering the cell suspension through 80 #m nylon filters, respectively. Lungs 
were harvested and ground through a cell strainer, followed by incubation with 2 ml of digestion 
buffer (RPMI 1640 medium containing 3mg/ml of collagenase A (Roche), 5% FBS and 10mM 
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HEPES) at 37°C for 1 hour. Red blood cells (RBCs) in the spleen, blood and lung were lysed 
with RBC lysis buffer (Gibco) and the cells were washed with complete RPMI. The cells were 
counted and 1-3 x106 cells were used for surface staining. Cells were washed twice with PBS 
plus 2% FBS before cytometry analsysis. For intracellular staining, splenocytes were stimulated 
with SIY peptide for 5 hours in the presence of GolgiPlug (BD Biosciences). Cells were washed 
twice with PBS with 2% FBS and stained with indicated antibodies. The cells were then fixed 
and stained with labeled antibodies using an intracellular staining kit (Cytofix/Cytoperm kit; BD 
Biosciences) according to the manufacture’s instructions. Stained cells were analyzed on either a 
FACSCalibur or AccuriTM C6 flow cytometer (BD Biosciences). 0.5-2 x 106 events were 
collected and analyzed with FlowJo software. Cell sorting was carried out with a MoFlo cell 
sorter or FACSAria (BD Biosciences). 
 
Retrovirus production and infection 
Retroviral pMIGw-GW gateway vector was constructed by inserting a gateway cassette at EcoRI 
site of the pMIGw vector (Addgene #9044) using a gateway construction kit (Invitrogen). All 
ORFs encoding 12 TFs were amplified with primers (Supplementary Table S3) and cDNA from 
mouse splenocytes and cloned into pMIGw-GW using the gateway cloning technology. shRNAs 
for specific TFs (Supplementary Table S4) were chosen from the predicted TRC library and 
cloned into pMKO.1 GFP retroviral vector (Addgene #10676). Briefly, synthesized single-strand 
sense and antisense oligonucleotides were annealed into double-strand oligonucleotides for short 
hairpin RNA in the annealing buffer (10mM TrisCl (pH7.5), 50mM NaCl and 1mM EDTA). The 
double-strand oligonucleotides were directly treated with T4 polynucleotide kinase (NEB) and 
ligated into pMKO.1 GFP vector) between AgeI and EcoRI sites. 
293FT cells were cultured to 60% confluency in 6-well plates. Cells were co-transfected 
with retroviral vector plasmid (4#g) and packing plasmids pCL-Eco (1#g) with 150#l DMEM 
and 15#l TransIT®-LT1 (Mirus) according to the manufacture’s instructions. On the second day, 
the culture was replaced with fresh medium. On the third day, supernatant was collected and 
filtered through a 0.45 #m low-protein binding membrane (Pall Life Science). Fresh viral 
supernatants were used for spin infection of CD8+ T cells in all experiments.  
For infection, cells from spleens and lymph nodes were harvested from 2C+RAG-/- mice, 
pooled and cultured in 6-well plates in the presence of SIY peptide (1#g/ml) in the complete 
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RPMI medium (RPMI 1640 supplemented with 10% FBS, 5mM HEPES, 2 mM glutamine, 
100U/ml penicillin, 100#g/ml streptomycin and 50#M #-mercaptoethanol (Invitrogen)). Two 
days later, activated 2C T cells were collected, washed and resuspended at 2 x 106 cells per ml in 
the complete RPMI medium. 1ml fresh retrovirus supernatants and 0.25ml 2C cells with a final 
concentration of 5µg/ml polybrene (American Bioanalytical) were added to one well of a 24-well 
plate and spun for 90min at 2500rpm at 32°C to infect T cells. 24 hours later, cells were 
collected for direct adoptive transfer, or resuspended and cultured in 3ml fresh RPMI medium 
with 100U/ml IL-2 (eBioscience). After culture for 24 hours, 2C T cells were analyzed for GFP 
expression by flow cytometry and prepared for injection into mice to generate in vivo memory T 
cells or further culture to generate in vitro memory T cells.  
 
Generation and recall proliferation of memory T cells  
To generate in vitro memory T cells, activated (and transduced) 2C T cells were cultured in 
complete RPMI medium supplemented with 5ng/ml IL-7 (Peprotech) for 7 days with change of 
fresh IL-7-supplemented medium every two days. Cells were analyzed for memory phenotype by 
flow cytometry on day 7. To test the recall proliferation, in vitro memory 2C T cells (1x105) 
were cultured with B6 splenocytes (5x105) in a 12 well plate in complete RPMI medium 
supplemented with 1 µg/ml SIY peptide and 100 units/ml IL-2. The numbers and phenotype of 
2C T cells were analyzed by flow cytometry 4 and 6 days later.  Alternatively, in vitro memory 
2C T cells (2x105) were transferred to B6 recipients and challenged with WSN-SIY virus. 2C 
cells were analyzed by flow cytometry 5 dpi.  
To generate in vivo memory T cells, activated and transduced 2C T cells were adoptively 
transferred into B6 recipients. Twenty-third days later, the frequency, phenotype and function of 
persisting 2C T cells were analyzed by flow cytometry. To assay for recall response, mice were 
infected with 100pfu WSN-SIY virus and the number and phenotype of 2C T cells in different 
organs were analyzed by flow cytometry 7 dpi. 
 
Bone marrow chimera mice 
Bone marrow cells were collected from the tiba and femur of 2C+Rag-/- mice. Stem and 
progenitor cells were enriched using a progenitor enrichment kit (Stemcell Technologies) 
according to the manufacture instructions. The enriched cells were cultured for 48 hours in 
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complete RPMI medium supplemented with IL-3 (30ng/ml), IL-6 (10ng/ml) and SCF (15ng/ml). 
The cells were resuspended at 2 x 106 cells per ml in complete RPMI. 600µl fresh retrovirus 
supernatants and 400µl cells plus a final concentration of 6 µg/ml polybrene were added to one 
well of a 24-well plate and spun for 90min at 2500rpm at 32°C. One the second day, cells were 
collected and washed and injected into Rag-/- mice that had been irradiated for 500rads 4 hours 
earlier. Eight weeks later, mice were bleeded to determine the reconstitution of CD8+ T cells and 
GFP proportion by flow cytometry. Twelve weeks later, cells were collected from spleen and 
analyzed for 2C T cell percentage and phenotype. Splenocytes containing 5x104 2C T cells were 
adoptively transferred into B6 mice followed by WSN-SIY infection. The number, phenotype 
and function of 2C T cells in the recipient mice were analyzed 7 and 30 dpi. To generate Bach2-/- 
chimeric mice, bone marrow cells from Bach2-/- mice 49 (kindly gift of Dr. Kazuhiko Igarash of 
Tohoko University, Japan) were directly injected into sublethally irradiated Rag2-/- mice. Eight 
weeks later, reconstitution of CD8+ T cells were verified by flow cytometry of peripheral blood 
mononuclear cells. Twelve weeks later, mice were infected with 50 pfu WSN-SIY virus and  30 
dpi SIY-specific CD8+ T cells in various tissues were identified by H-2Kb DimerX (BD 
Biosciences) loaded with SIY peptide plus anti-CD8 by flow cytometry. 
 
Gene perturbations and quantitative PCR 
To perturb the network, selected TFs were overexpressed in CD8+ 2C T cells by retrovirus 
transduction as described above.  Transduced 2C T cells were cultured in the presence of IL-7 
for 24 hours and GFP+ 2C T cells were purified by sorting (>95% viable by PI staining). Total 
RNA was extracted from the purified 2C T cells using RNeasy micro kit (Qiagen) according to 
the manufacture’s instructions. First strand cDNA was synthesized from 1 µg total RNA using 
the TaqMan® Reverse Transcription Reagents (ABI). 2 µl of diluted cDNA (total 200 µl) were 
used as template for the quantitative PCR with LightCycler®480 SYBR Green and 
LightCycler®480 machine (Roche). For each TF transduced CD8+ T cells, the transcript levels 
of 12 TFs were measured by qPCR using gene specific primers (Supplementary Table S5). To 
measure the transcript level of TFs in naïve, effector and memory CD8+ T cells, naïve 2C T cells 
were adoptively transferred into B6 mice followed with WSN-SIY virus infection, effector and 
memory 2C T cells were sorted from spleen 7 dpi and 30 dpi, respectively. Total RNA was 
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isolated from naïve, effector and memory 2C T cells and used for quantification of the transcript 
level of each TF by PCR. 
 
ChIP and ChIP-PCR 
A Millipore ChIP kit was used for chromatin immunoprecipitation. DNA-protein complexes 
were cross-linked with formaldehyde at a final concentration of 1%, sheared by sonication to 
800~1000bp, followed by precipitation with nonspecific goat anti-IgG (Sigma) or rabbit anti-IgG 
(Cell Signaling Technology) or chromatin ChIP-grade anti-Sox4 (C-20, Santa Cruz 
Biotechnology), anti-Tcf7 (H-118, Santa Cruz Biotechnology), and anti-Eomes (ab23345, 
Abcam). DNA-protein complex was eluted, and ChIP DNA was purified by PCR purification kit 
(Qiagen). The promoter regions of the indicated TFs or MSGs were amplified using specific 
primers (Supplementary Table S6). Primers used to amplify the promoter regions were all within 
this 1 kb upstream of the transcription-starting site. For ChIP of Bach2 with anti-Bach2 (E-16, 
Santa Cruz Biotechnology), cross-linked DNA-protein complexes were digested to 400~600bp 
by micrococcal nuclease (Cell Signaling Technology).  
 
Protein extraction and western blotting 
Proteins were extracted from transduced 2C T cells with the CelLyticTM Lysis Reagent (Sigma). 
Samples containing 20µg total protein (BCA™ Protein Assay Kit, Pierce Biotechnology) were 
resolved on a 10% SDS-PAGE gel and electro-transferred onto a PVDF membrane (Millipore 
Corporation). The membrane was blocked in 5% (w/v) fat-free milk in PBST (PBS containing 
0.1% Tween-20). The blot was hybridized overnight with primary antibodies: anti-GAPDH 
(HRP-conjugated, Cell Signaling Technology, 1:2000), anti-Sox4 (C-20, Santa Cruz 
Biotechnology, 1:500), anti-Bach2 (AP10133b, Abgent, 1:500), anti-Id3 (6-1, CalBioreagents, 
1:2500), anti-Blimp-1 (6D3, eBioscience, 1:1000), anti-Bcl2 (BioLegend, 1:500), anti-Bcl6 
(BioLegend, 1:2000), anti-pFoxO1 (Cell Signaling Technology, 1:1000), anti-CDK4 (Cell 
Signaling Technology, 1:1000), anti-CDK6 (Cell Signaling Technology, 1:1000), anti-Rb-p780 
(Cell Signaling Technology, 1:1000), anti-Rb-p795 (Cell Signaling Technology, 1:1000) and 
anti-p27kip (Cell Signaling Technology, 1:1000) according to the recommended dilution in 5% 
fat free milk. The blot was washed twice in PBST and then incubated with HRP-conjugated 
secondary antibody (Cell Signaling Technology: anti-Rabbit, 1:2000; anti-mouse,1:3000. Santa 
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Cruz Biotechnology: anti-Rat, 1:2000; anti-Goat 1:3000) in 5% fat-free milk. The membrane was 
washed twice in PBST and subjected to protein detection by ECL Plus Western Blotting 
Detection System (GE Healthcare) before being exposed to a Koda BioMax XAR film. The 
membrane was stripped and re-blotted with the rabbit anti-mouse HRP-conjugated anti-Gapdh 
antibody (Cell Signaling Technology) for protein loading control.  
 
Statistical analysis 
Statistical significance was determined with the two-tailed unpaired or paired Student’s t-test.  P-
values for MRA and promoter enrichment results were calculated with a binomial test. The 
FDRs were computed with q = p*n/i, (p = P value, n = total number of tests, i = sorted rank of 
P$value).  
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Figure Legends  
 
Figure 1 | Construction of regulatory network of memory CD8+ T cells. (a) Schematic 
diagram of regulatory network analysis for identifying key TFs. N, E, and M, naïve, effector and 
memory CD8+ T cells, respectively.  (b) The regulatory module of the top 10 TFs (orchid circles) 
and their MSGs (blue). c, ChIP-PCR analysis of Sox4, Tcf7 and Emoes-regulated MSGs. ChIP 
was carried out with CD8+ T cells expressing the 2C TCR using antibodies specific for Sox4, 
Tcf7 or Eomes or control IgG antibodies. Promoter regions of the indicted genes were amplified 
using the precipitated DNA. Shown are PCR products after electrophoresis.  
 
Figure 2 | Construction of perturbation network of TFs in CD8+ T cells. (a) ChIP-PCR 
analysis. ChIP was carried out with 2C T cells using antibodies specific for Sox4, Tcf7 or Eomes 
or control IgG antibodies. Promoter regions of the indicted genes were then amplified using the 
precipitated DNA. Shown are PCR products after electrophoresis. (b) Perturbation network 
based on Table 3.  (c) An example of network motifs from the perturbation network. 
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Figure 3 | Effect of overexpression and knockdown of TFs on memory CD8+ T-cell recall 
proliferation. Naïve 2C T cells were activated in vitro with SIY peptide and then transduced 
with retroviruses expressing Sox4, Bhlhe40, Bach2 or Runx2 or expressing shRNA specific for 
one of the TFs. The cells were cultured in the presence of IL-7 to induce memory T cell 
development. The resulting memory 2C T cells were either activated in vitro with SIY peptide or 
transferred into mice and activated by WSN-SIY virus infection. The proportion of GFP+ 
(transduced) versus GFP- (non-transduced) 2C T cells was quantified 4 and 6 days post 
stimulation in vitro and in draining lymph node (DLN) 5 days post infection (dpi). Shown are 
proportion of GFP+ 2C T cells that overexpressed Sox4, Bhlhe40, Bach2 or Runx2 among total 
2C T cells in vitro (a) and in vivo (b) or that expressed shRNA specific for Sox4, Bhlhe40, Bach2 
or Runx2 among total 2C T cells is in vitro (c) and in vivo (d). Each line was one independent 
experiment with one sample per time point for the in vitro experiments and one or two mice per 
in vivo experiment. Data shown are mean ± s.e.m. Pairwise two-tailed t-tests were used for 
statistical analyses. * P<0.05; ** P<0.01.  
 
Figure 4 | Bach2 promotes recall proliferation of memory CD8+ T cells. (a) Scheme of 
experimental protocol. (b-d) Phenotype and function of persisting memory 2C cells. Twenty-two 
days post transfer, single cell suspension was prepared from spleen and analyzed for CD8, 
Thy1.1, GFP plus CD62L or IL-7R directly or stimulated in vitro with SIY peptide for 5 hours 
before staining for CD8, Thy1.1, GFP plus intracellular IFN! or TNF". Comparison of GFP 
versus Thy1.1 (b) staining profiles of live cells between vector control and Bach2 overexpression 
group. Comparison of CD62L and IL-7R (c) or IFN! and TNF" expression (d) between GFP+ 
and GFP- 2C T cells. Gray trace, nontransduced (GFP-) 2C T cells; black trace, transduced (GFP+) 
2C T cells; dash gray trace, isotype control for intracellular staining; dash black trace, IL-7R 
staining of naïve 2C T cells. (e) Recall responses of persisting memory 2C T cells in vivo. Some 
recipient mice were infected with WSN-SIY 23-25 days post transfer and the proportions of 
GFP+ and GFP- 2C T cells in the DLN and spleen was quantified by flow cytometry 7 dpi. 
Comparison of proportions of GFP+ 2C T cells in the DLN and spleen before (d23) and after 
antigen restimulation (7dpi). Representative data from three independent experiments with 2-3 
mice per group per experiment are shown as mean ± s.e.m. Two-tailed student’s t-tests were used 
for statistical analyses. ** P<0.01; n.s., not significant. 
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Figure 5 | Bach2 promotes memory CD8+ T cell development. (a) Scheme of experimental 
protocol for b-f.  (b-e) Effect of Bach2 overexpression on memory T cell development. b,c, 
Persistence and phenotype of transferred 2C T cells over time. Seven and 30 dpi, 2C T cells in 
various organs were analyzed for CD62L, IL-7R, Klrg1, CD27 and IFN! as in Fig. 4. Shown are 
histograms of CD62L, IL-7R, Klrg1 and CD27 expression of Thy1.1+ CD8+ 2C T cells 7 (b) and 
30 dpi (c). Gray trace, nontransduced (GFP-) 2C T cells; black trace, transduced (GFP+) 2C T 
cells. Representative data from 6 mice in 3 independent experiments are shown. (d) Proportion 
of GFP+ transduced 2C cells in different organs normalized to the average of the blood at 7 dpi. 
(e) Total Bach2-transduced 2C T cells (GFP+) in the spleen 7 and 30 dpi. (f) Effect of Bach2 
knockdown on memory T cell development. Proportion of Bach2-knockdown 2C T cells (GFP+) 
in different organs normalized to the average of the blood at 7 dpi. (g) Effect of Bach2 knockout 
on memory T cell development. Chimera mice were constructed by injecting Bach2-/- and 
Bach2+/+ bone marrow cells into sublethally irradieated Rag2-/- recipient mice. Following 
reconstitution (3 months later), mice were infected with WSN-SIY virus and 30 dpi cells from 
DLN and spleen were stained for H-2Kb-SIY and anti-CD8. Shown are staining profiles of H-
2Kb-SIY versus CD8.  The numbers in the plots indicate percentage of SIY-specific memory 
CD8+ T cells. The numbers in the boxes indicate the number of SIY-specific memory CD8+ T 
cells (top) and total CD8+ T cells (bottom). Representative data from three independent 
experiments with 2-3 mice per group per experiment (d, e) and from two independent 
experiments with 3-4 mice per group per experiment (f) are shown as mean ± s.e.m. Two-tailed 
student’s t-tests were used for statistical analyses. * P<0.05; ** P<0.01. 
 
Figure 6 | Bach2 promotes memory CD8+ T cell development. (a) Scheme of experimental 
protocol. (b-e) Persistence and phenotype of transferred CD8+ T cells over time. Seven and 30 
dpi, 2C T cells in various organs were analyzed as in Fig. 4. Shown are histograms of CD62L, 
IL-7R, Klrg1, IFN! and TNF" expression of Thy1.1+ CD8+ 2C T cells 7 (b) and 30 dpi (c). Gray 
trace, nontransduced (GFP-) 2C T cells; black trace, transduced (GFP+) 2C T cells; dash gray 
trace, isotype control for intracellular staining. Representative data from 9-12 mice in 3 
independent experiments are shown. (d) Proportion of GFP+ transduced 2C cells in different 
organs normalized to the average of the blood at 7 dpi.  (e) Total Bach2-transduced 2C T cells 
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(GFP+) in the spleen 7 and 30 dpi. Data from three independent experiments with 3-4 mice per 
group per experiment are shown as mean ± s.e.m. Two-tailed student’s t-tests were used for 
statistical analyses. * P<0.05; ** P<0.01. 
 
Figure 7 | Bach2 promotes proliferation of CD8+ T cells. (a) 2C cells were activated in vitro 
and transduced with retroviruses expressing GFP alone (vector) or GFP plus Bach2 and cultured 
in the presence of either IL-2 or IL-7. The proportion of GFP+ 2C T cells was quantified. Shown 
(mean ± s.e.m.) are changes in proportion of GFP+ cells over time from four independent 
experiments. Two-tailed student’s t-tests were used for statistical analyses. ** P<0.01. (b) Bach2 
transduced 2C T cells (day 4 in Fig. 7a) were labeled with eFluor®670 and cultured in the 
presence of IL-2 for four days.  Shown are representative histograms of eFluor®670 from one of 
the two experiments. Gray trace, nontransduced (GFP-) 2C T cells; black trace, transduced (GFP+) 
2C T cells. (c) Sox4-Bach2-Prdm1-Id3 regulatory motif identified in perturbation network. (d) 
Bach2 inhibits Prdm1 expression but promotes Id3 expression. Activated 2C T cells were 
transduced with retroviruses expressing GFP alone (vector) or GFP plus Bach2, Sox4 or Id3. The 
levels of the indicated TFs were assayed by Western blotting. Shown are representative Western 
blotting and the average expression level quantified from three independent experiments. (e-f) 
Bach2 binds to Prdm1 and Id3 promoter. Activated 2C T cells were cultured with IL-7 for 24 
hours and harvested for ChIP using anti-Bach2. DNA was used to amplify different parts of the 
Prdm1 (e) and Id3 (f) promoter region indicated by i-v. The location of the predicted Bach2 
binding motif was indicted as triangle. Data are from two independent experiments, error bar: 
SEM. (g) Bach2 affects Rb phosphorylation and p27kip expression. Activated 2C T cells were 
transduced with retroviruses expressing GFP alone (vector) or GFP plus Bach2 and cultured for 
8 days (Fig. 7a). The levels of phosphorylated Rb and FoxO1, CDK4, CDK6, Bcl6, Bcl2 and 
p27kip in the transduced 2C T cells were assayed by Western blotting.  
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Table 1. Ranking of the 21 key TFs identified by master regulator analysis. 
TF #MSG P-value ISP* DBM FDR ESG MSG 
qPCR 
E/N 
qPCR 
M/N Reference gene functions# Ref. 
Sox4 50 9.55E-10 YES SORY 0.0001 YES YES -4.305 -5.845 Th2 differentiation 50 
Tcf7 40 1.10E-06 YES LEFF 0.0010 YES NO -3.71 -0.37 Promote memory  7, 9 
Eomes 34 1.03E-06 YES BRAC 0.0021 YES YES 1.99 3.48 Effector and memory  4, 5 
Bhlhe40 27 2.50E-05 YES HESF 0.3353 YES YES 2.72 4.215 CD8+ T cell activation 51 
Prdm1 26 2.90E-05 YES PRDF - YES NO 4.185 4.5 Effector/inhibit memory 16, 17 
Klf2 24 0.000587 YES KLFS 0.1135 NO NO -2.01 -0.63 Homeostasis/memory  10 
Bach2 22 0.000229 YES AP1R 0.0151 YES NO -3.77 -0.935 - 
 Runx2 21 0.000365 YES HAML 0.0031 YES YES 0.19 2.775 Early T cell development 52 
Id2 20 0.000319 YES - - YES YES 0.265 2.645 KO promotes memory 13, 14 
Stat4 17 0.002650 YES STAT 0.2503 NO NO -2.33 0.935 Effector and memory  53, 54 
Runx3 15 0.002869 YES HAML 0.0031 NO NO -2.37 -1.925 Cooperation with Tbx21  55 
Id3 14 0.005424 YES - - NO NO -3.695 -1.995 Promote memory  15 
Nfatc2 12 0.007564 YES NFAT 0.0127 NO NO - - TCR signaling 56 
Gata3 11 0.012973 YES GATA 0.0425 NO NO - - Th2 differentiation 57 
Ikzf1 11 0.038617 YES IKRS 0.0208 NO NO - - IL2/TCR signaling 58 
Nfatc1 11 0.038617 YES NFAT 0.0127 NO NO - - PD-1/TCR signaling 59 
Jun 10 0.019089 YES AP1F 0.0046 NO NO - - AP-1 complex 60 
Nfe2l2 10 0.019089 YES AP1R 0.0151 NO NO - - Protect memory 61 
Tbx21 9 0.036556 YES BRAC 0.0021 NO NO 6.215 3.165 Effector and memory  4, 5 
Jund 9 0.028085 YES AP1F 0.0046 NO NO - - AP-1 complex 60 
Maf 9 0.025971 YES AP1R 0.0151 YES NO - - - 
 #MSG: the total number of MSG regulated directly by the TF; * ISP: immune system phenotype; DBM, DNA binding motif; FDR, 
false discovery rate; ESG, effector signature genes; MSG, memory signature genes; qPCR E/N, log2 gene expression fold-changes 
between effector and naïve CD8+ T cells; qPCR M/N, log2 gene expression fold-changes between memory and naïve CD8+ T cells; 
#gene function reported in T cells. Grey marked TFs that have been reported as playing important roles in memory CD8+ T cell 
development or function.  
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Table 2. Summary of the ChIP-PCR results. 
TF Sox4 Tcf7 Eomes Total 
No. MSG target 41 36 26 103 
No. tested target 12 14 9 35 
No. positive 10 (83.3%) 12 (85.7%) 6 (66.7%) 28 (80%) 
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Table 3. Perturbation analysis. 
Gene Sox4 Tcf7 Eomes Bhlhe40 Prdm1 Klf2 Bach2 Id2 Runx2 Stat4 Id3 Tbx21* 
Sox4 7.94 -1.38 1.77 -0.62 -3.17 -0.28 -0.93 -0.48 -0.05 -0.70 -0.83 1.21 
Tcf7 -1.79 2.44 -0.03 -0.21 -2.01 -0.50 0.88 -0.39 0.04 -2.16 0.31 -0.64 
Eomes -2.28 -1.11 5.29 0.38 -0.08 -0.26 -0.64 -0.10 0.85 -0.55 0.54 -2.31 
Bhlhe40 -2.03 0.41 1.09 3.88 0.02 1.99 0.32 0.31 0.14 -0.41 0.68 0.62 
Prdm1 -0.14 -1.48 2.04 1.13 5.19 1.34 -1.62 -0.17 0.20 0.08 -0.39 1.30 
Klf2 0.85 -0.78 -1.10 -0.55 -1.49 4.06 -1.52 -0.73 -0.07 -1.33 -1.51 -0.57 
Bach2 1.37 0.75 0.35 0.00 0.22 1.40 4.41 -0.18 0.78 0.01 0.07 0.15 
Id2 -2.24 1.10 0.46 0.38 0.24 0.66 0.09 4.98 0.93 -0.06 0.18 0.54 
Runx2 -1.64 0.41 -0.51 -0.22 -0.02 0.91 -0.50 -0.82 3.71 -0.54 -0.03 -0.77 
Stat4 -1.45 -0.26 -1.78 0.14 0.80 0.24 0.22 -0.01 0.85 2.32 0.41 -0.81 
Id3 2.61 0.23 -1.32 0.47 -0.23 0.72 2.02 -1.03 0.25 0.73 7.44 -1.09 
Tbx21 -1.68 -0.26 -0.22 0.12 -0.34 1.42 0.50 0.93 1.29 -2.29 1.17 6.54 
 !  The highlighted 12 TFs (first row) were overexpressed individually in 2C T cells and the level of their transcripts of each TFs was 
quantified by real-time PCR. Expression data was normalized to the empty vector control and then log2 transformed. Changes in 
transcript levels for !2 fold are marked orange (up-regulated) or green (down-regulated). The overexpressed TFs are marked red. 
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Supplementary Figure S1. The regulatory network of CD8+ T cells showing 3,219 
interactions involving 154 MSGs and 276 expressed putative TFs.  The gray nodes 
indicate TFs and the red nodes MSGs. 
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Supplementary Figure S2. (a) The cumulative percentage of MSGs that are regulated by 
the identified 21 TFs. The order that TFs were plotted is the same as they were ranked in 
Table 1. (b) The regulatory module of Sox4 and Tcf7 (orchid circles) and MSGs (blue 
circles).  
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Supplementary Figure S3: Identification of TFs in the upstream of the perturbation 
network.  Shown is the plotting of the number of downstream and upstream interacting 
TFs for each TF in the perturbation network.  
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Supplementary Figure S4. Examples of network motifs from the perturbation network. 
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Supplementary Figure S5. Regulation of Eomes and Tbx21 by Sox4, Tcf7, Eomes and 
Tbx21.  2C T cells were transduced with retroviruses expressing GFP (vector) or GFP 
plus Sox4, Tcf7, Eomes or Tbx21. Expression of Eomes and Tbx21 was analyzed by 
intracellular staining and flow cytometry. Histograms compare Eomes and Tbx21 
expression in non-transduced (GFP-, gray lines) and transduced (GFP+, black lines) T 
cells. The numbers indicate MFI. 
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Supplementary Figure S6. Phenotype of in vitro memory T cells. Activated 2C T cells 
were cultured in vitro with IL-7 for 7 days to induce in vitro memory T cells. (a) Naïve, 
effector and in vitro memory 2C T cells were stained for CD44, CD62L, IL-7R, CCR7 
and CD122 followed by cytometry. (b) Quantitative PCR analysis of gene expression of 
key memory genes (Eomes, Tbx21, Prdm1, Il7r, Sell and Klrg1) in naïve, activated and in 
vitro memory 2C T cells.  
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Supplementary Figure S7. Effect of overexpression of Sox4, Bhlhe40, Bach2 and Runx2 
on recall proliferation of memory CD8+ T cells in vivo. Naïve 2C T cells were activated 
in vitro with SIY peptide and then transduced with retroviruses expressing Sox4, Bhlhe40, 
Bach2 or Runx2. The cells were cultured in the presence of IL-7 to derive memory T cells. 
The resulting memory 2C T cells were transferred into B6 mice and activated with WSN-
SIY virus. The proportion of GFP+ (transduced) versus GFP- (non-transduced) 2C T cells 
was quantified in various organs 5 dpi. Shown is proportion of GFP+ 2C T cells that 
overexpressed Sox4, Bhlhe40, Bach2 or Runx2 among total 2C T cells in vivo. Data are 
from three independent experiments with 1-2 mice per group per experiment, shown as 
mean ± s.e.m. Two-tailed student’s t-tests were used for statistical analyses. 
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Supplementary Figure S8. Knowdown efficiency of shRNAs targeting Sox4, Bhlhe40, 
Bach2 and Runx2. The indicated shRNA vectors were transduced individually in 2C T 
cells and the level of the target transcript was quantified by real-time PCR 48 hours later. 
Expression data was normalized to the empty vector control. Data from three independent 
experiments are shown as mean ± s.e.m. Two-tailed student’s t-tests were used for 
statistical analyses. 
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Supplementary Figure S9. Overexpression of Eomes and Klf2 affects recall response of in 
vitro generated memory CD8+ T cells. 2C T cells were activated and transduced with 
retroviruses expressing GFP plus Eomes or Klf2. The cells were cultured in the presence 
of IL-7 to derive memory T cells. The resulting memory 2C cells were either activated in 
vitro with SIY peptide or transferred into mice and activated with WSN-SIY virus. The 
proportion of GFP+ (transduced) versus GFP- (non-transduced) 2C T cells was quantified 
4 and 6 days post stimulation in vitro and in DLN 5 dpi.  Shown are Thy1.1 vs. GFP 
staining profiles of CD8+ 2C T cells (a) and proportion of GFP+ 2C T cells that 
overexpressed Eomes or Klf2 among total 2C T cells in vitro (b) and in vivo (c). Each line 
was one independent experiment with one sample per time point for the in vitro 
experiments and one or two mice per in vivo experiment. * P<0.05; ** P<0.01. Pairwise 
two-tailed t-tests were used for statistical analyses. 
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Supplementary Figure S10. Bach2 promotes memory CD8+ T cell development. Naïve 
2C T cells were activated in vitro with SIY peptide and then transduced with retroviruses 
expressing Bach2. The cells were adoptively transferred into mice and activated with 
WSN-SIY virus. Phenotype of 2C T cells in various organs was analyzed for CD27. 
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Shown are histograms CD27 expression of Thy1.1+ CD8+ 2C T cells 7 (a) and 30 dpi (b). 
Gray trace, nontransduced (GFP-) 2C T cells; black trace, transduced (GFP+) 2C T cells. 
IL-2 and IFN! expression 2C T cells 30 dpi were analyzed as Fig.4. Shown is IL-2 vs. 
IFN! staining profile of Thy1.1+ CD8+ 2C T cells (c). Representative data from 6 mice in 
3 independent experiments are shown.  
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure S11. Bach2 promotes memory CD8+ T cell development. Bone 
marrow progenitor cells isolated from 2C TCR transgenic mice were transduced with 
retroviruses expressing GFP alone (vector) or GFP plus Bach2 and adoptively transferred 
into sublethally irradiated RAG2-/- mice to generate naïve 2C T cells that express GFP or 
GFP plus Bach2. Three to 4 months later, 2C T cells generated in RAG2-/- recipients were 
analyzed for Thy1.1, CD8 plus CD25, CD62L or IL-7R. (a) Comparison of CD25, 
CD62L and IL-7R expression between GFP+ and GFP- 2C T cells (Thy1.1+ CD8+). The 
resulting transduced and nontransduced naïve 2C cells were adoptively transferred into 
B6 mice followed by infection with WSN-SIY influenza virus. The frequency, phenotype 
and function of 2C T cells were analyzed 7 dpi. (b) Quantification of CD62L+Klrg1- 
memory 2C T cell precursors in the DLN and spleen. Data from three independent 
experiments with 3-4 mice per group per experiment are shown as mean ± s.e.m. Two-
tailed student’s t-tests were used for statistical analyses. *P<0.05, **P<0.01.  
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Supplementary Figure S12. Bach2 is required for memory CD8+ T cell development. 
Naïve 2C T cells were activated in vitro with SIY peptide and then transduced with 
retroviruses expressing the shRNA specific for Bach2. The cells were adoptively 
transferred into mice and activated with WSN-SIY virus. 2C T cells were analyzed 7 and 
30 dpi as in Fig. 4. Shown are histograms of CD62L, IL-7R, CD27, Klrg1 and IFN! 
expression of Thy1.1+ CD8+ 2C T cells in the spleen 7 (a) and 30 dpi (b). Gray trace, 
nontransduced (GFP-) 2C T cells; black trace, transduced (GFP+) 2C T cells. 
Representative data from 6-8 mice in two independent experiments are shown. (c) Total 
vector or shBach2 transduced 2C T cells (GFP+) in the spleen 7 and 30 dpi. 
Representative data from 6-8 mice in two independent experiments are shown as mean ± 
s.e.m. Two-tailed student’s t-tests were used for statistical analyses. *P<0.05;  
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Supplementary Figure S13. Prdm1 inhibits Bach2-mediated proliferation of CD8+ T cells. 
2C cells were activated in vitro and transduced with retroviruses expressing GFP alone 
(vector), GFP plus Bach2 or GFP plus Prdm1 and Bach2 (Prdm1-2A-Bach2) and cultured 
in the presence of IL-2. The proportion of GFP+ 2C T cells was quantified. Shown are 
changes in proportion of GFP+ cells over time from three independent experiments. Two-
tailed student’s t-tests were used for statistical analyses, error bar: s.e.m. ** P<0.01. 
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Supplementary Figure S14. Enhanced proliferation and survival of memory CD8+ T cells. 
Naïve 2C cells were activated in vitro and transduced with retroviruses expressing GFP 
alone (vector) or GFP plus Bach2 and cultured in the presence of IL-7 to derive memory 
T cells. In vitro memory 2C T cells were labeled with eFluor®670 and adoptively 
transferred into Rag2-/- mice. 2C T cells in the spleen were analyzed 14 days later. Shown 
are representative histograms of eFluor®670 from one of the two experiments. Gray trace, 
nontransduced (GFP-) 2C T cells; black trace, transduced (GFP+) 2C T cells. 
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Supplementary Figure S15. The DNA gels of ChIP-PCR. (a) The DNA gels of ChIP-PCR 
for Fig. 1c. Representative data from 3 independent experiments. (b) The DNA gels of 
ChIP-PCR for Fig. 2a. Representative data from 3 independent experiments. 1, input 
chromatin; 2, IPed chromatin by TF Abs; 3, IPed chromatin by IgG. 
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Supplementary Figure S16. The Western blotting gels. (a) The protein gels of blotting 
Sox4, Bach2, Prdm1 and Id3 for Fig. 7d. Representative data from 3 independent 
experiments. (b) The protein gels of blotting pRb780, pRb795,pFoxO1, Bcl2,Bcl6, CDK4, 
CDK6 and p27kip for Fig. 7g.  Marker is the PageRulerTM Prestained Protein Ladder 
(Thermo Scientific). Representative data are from 3 independent experiments.  
Supplementary Table S1. List of 386 gene expression profiles of CD8+ T cells used in the present study.
Index Platform GSE ID ArrayID Array Name Title Classification
1 GPL339 GSE2059 GSM35848 control 1 Control of naïve CD8+ T cells N
2 GPL339 GSE2059 GSM37078 control 2 Control of naïve CD8+ T cells N
3 GPL339 GSE2059 GSM37079 control 3 Control of naïve CD8+ T cells N
4 GPL339 GSE2059 GSM37080 control 4 Control of naïve CD8+ T cells N
5 GPL339 GSE2059 GSM37081 control 5 Control of naïve CD8+ T cells N
6 GPL339 GSE2059 GSM37117 IL--15 1 IL15 of naïve CD8+ T cells N
7 GPL339 GSE2059 GSM37118 IL--15 2 IL15 of naïve CD8+ T cells N
8 GPL339 GSE2059 GSM37119 IL--15 3 IL15 of naïve CD8+ T cells N
9 GPL339 GSE2059 GSM37120 IL--15 4 IL15 of naïve CD8+ T cells N
10 GPL339 GSE2059 GSM37121 IL--15 5 IL15 of naïve CD8+ T cells N
11 GPL339 GSE2059 GSM37122 IL--21 1 IL21 of naïve CD8+ T cells N
12 GPL339 GSE2059 GSM37123 IL--21 2 IL21 of naïve CD8+ T cells N
13 GPL339 GSE2059 GSM37124 IL--21 3 IL21 of naïve CD8+ T cells N
14 GPL339 GSE2059 GSM37125 IL--21 4 IL21 of naïve CD8+ T cells N
15 GPL339 GSE2059 GSM37126 IL--21 5 IL21 of naïve CD8+ T cells N
16 GPL339 GSE2059 GSM37128 IL--15+IL-21 1 IL21 of naïve CD8+ T cells N
17 GPL339 GSE2059 GSM37163 IL--15+IL-21 2 IL15+IL21 of naïve CD8+ T cells N
18 GPL339 GSE2059 GSM37164 IL--15+IL-21 3 IL15+IL21 of naïve CD8+ T cells N
19 GPL339 GSE2059 GSM37165 IL--15+IL-21 4 IL15+IL21 of naïve CD8+ T cells N
20 GPL339 GSE2059 GSM37166 IL--15+IL-21 5 IL15+IL21 of naïve CD8+ T cells N
21 GPL339 GSE4938 GSM111271 wt CD8 M CD8 M of Gfi1-WT N
22 GPL339 GSE4938 GSM111269 ko CD8 N CD8 N of Gfi1-KO N
23 GPL339 GSE4940 GSM111286 ko 501_0h 0hr T Gfi1-KO activated by anti-CD3&CD28 N
24 GPL339 GSE4940 GSM111287 ko 501_4h 4hr T Gfi1-KO activated by anti-CD3&CD28 E
25 GPL339 GSE4940 GSM111288 ko 501_8h 8hr T Gfi1-KO activated by anti-CD3&CD28 E
26 GPL339 GSE4940 GSM111289 ko 501_24h 24hr T Gfi1-KO activated by anti-CD3&CD28 E
27 GPL339 GSE4940 GSM111290 wt 502_0h 0hr T Gfi1-WT activated by anti-CD3&CD28 E
28 GPL339 GSE4940 GSM111291 wt 502_4h 4hr T Gfi1-WT activated by anti-CD3&CD28 E
29 GPL339 GSE4940 GSM111292 wt 502_8h 8hr T Gfi1-WT activated by anti-CD3&CD28 E
30 GPL339 GSE4940 GSM111293 wt 502_24h 24hr T Gfi1-WT activated by anti-CD3&CD28 E
31 GPL339 GSE10093 GSM254977 Spleen CD8 T cells DMSO1 Spleen CD8 T cells with DMSO N
32 GPL339 GSE10093 GSM254983 Spleen CD8 T cells DMSO2 Spleen CD8 T cells with DMSO N
33 GPL339 GSE10093 GSM254976 Spleen CD8 T cells TCDD1 Spleen CD8 T cells with TCDD
34 GPL339 GSE10093 GSM254978 Spleen CD8 T cells TCDD2 Spleen CD8 T cells with TCDD
35 GPL339 GSE3565 GSM81921 DUSP1-/- control replicate 1 DUSP1-/- control
36 GPL339 GSE3565 GSM81922 DUSP1-/- control replicate 2 DUSP1-/- control
37 GPL339 GSE3565 GSM81923 DUSP1-/- control replicate 3 DUSP1-/- control
38 GPL339 GSE3565 GSM81924 DUSP1-/- LPS replicate 1 DUSP1-/- LPS
39 GPL339 GSE3565 GSM81925 DUSP1-/- LPS replicate 2 DUSP1-/- LPS
40 GPL339 GSE3565 GSM81926 DUSP1-/- LPS replicate 3 DUSP1-/- LPS
41 GPL339 GSE3565 GSM81927 DUSP1+/+ control replicate 1 DUSP1+/+ control
42 GPL339 GSE3565 GSM81928 DUSP1+/+ control replicate 2 DUSP1+/+ control
43 GPL339 GSE3565 GSM81929 DUSP1+/+ control replicate 3 DUSP1+/+ control
44 GPL339 GSE3565 GSM81930 DUSP1+/+ LPS replicate 1 DUSP1+/+ LPS
45 GPL339 GSE3565 GSM81931 DUSP1+/+ LPS replicate 2 DUSP1+/+ LPS
46 GPL339 GSE3565 GSM81932 DUSP1+/+ LPS replicate 3 DUSP1+/+ LPS
47 GPL339 GSE5811 GSM135705 B1_saline_overexpressor_422 saline_overexpressor_422
48 GPL339 GSE5811 GSM135706 B2_saline_overexpressor_422 saline_overexpressor_422
49 GPL339 GSE5811 GSM135707 B3_saline_overexpressor_422 saline_overexpressor_422
50 GPL339 GSE5811 GSM135708 B4_pseudomonas_overexpressor_422 pseudomonas_overexpressor_422
51 GPL339 GSE5811 GSM135709 B5_pseudomonas_overexpressor_422 pseudomonas_overexpressor_422
52 GPL339 GSE5811 GSM135710 B6_pseudomonas_overexpressor_422 pseudomonas_overexpressor_422
53 GPL339 GSE5811 GSM135711 R1_saline_wildtype_422 saline_wildtype_422
54 GPL339 GSE5811 GSM135712 R2_saline_wildtype_422 saline_wildtype_422
55 GPL339 GSE5811 GSM135713 R4_saline_wildtype_422 saline_wildtype_422
56 GPL339 GSE5811 GSM135714 R5_Pseudomonas_wildtype_422 Pseudomonas_wildtype_422
57 GPL339 GSE5811 GSM135715 R6_Pseudomonas_wildtype_422 Pseudomonas_wildtype_422
58 GPL339 GSE5811 GSM135716 R7_Pseudomonas_wildtype_422 Pseudomonas_wildtype_422
59 GPL339 GSE5811 GSM135717 B2_saline_overexpressor_48 saline_overexpressor_48
60 GPL339 GSE5811 GSM135718 B3_saline_overexpressor_48 saline_overexpressor_48
61 GPL339 GSE5811 GSM135719 B5_Pseudomonas_overexpressor_48 Pseudomonas_overexpressor_48
62 GPL339 GSE5811 GSM135720 B6_Pseudomonas_overexpressor_48 Pseudomonas_overexpressor_48
63 GPL339 GSE5811 GSM135721 R2_saline_wildtype_48 saline_wildtype_48
64 GPL339 GSE5811 GSM135722 R3_saline_wildtype_48 saline_wildtype_48
65 GPL339 GSE5811 GSM135723 R5_Pseudomonas_wildtype_48 Pseudomonas_wildtype_48
66 GPL339 GSE5811 GSM135724 R6_Pseudomonas_wildtype_48 Pseudomonas_wildtype_48
67 GPL339 GSE5811 GSM135725 C1_CLP_overexpressor_12 CLP_overexpressor_12
68 GPL339 GSE5811 GSM135726 C2_CLP_overexpressor_12 CLP_overexpressor_12
69 GPL339 GSE5811 GSM135727 C3_CLP_overexpressor_12 CLP_overexpressor_12
70 GPL339 GSE5811 GSM135728 C4_CLP_overexpressor_12 CLP_overexpressor_12
71 GPL339 GSE5811 GSM135729 C5_CLP_overexpressor_12 CLP_overexpressor_12
72 GPL339 GSE5811 GSM135730 C6_CLP_wildtype_12 CLP_wildtype_12
73 GPL339 GSE5811 GSM135731 S1_sham_overexpressor_12 sham_overexpressor_12
74 GPL339 GSE5811 GSM135732 S2_sham_overexpressor_12 sham_overexpressor_12
75 GPL339 GSE5811 GSM135733 S3_sham_overexpressor_12 sham_overexpressor_12
76 GPL339 GSE5811 GSM135734 S4_sham_overexpressor_12 sham_overexpressor_12
77 GPL339 GSE5811 GSM135735 S5_sham_overexpressor_12 sham_overexpressor_12
78 GPL339 GSE5811 GSM135736 S6_Sham_wildtype_12 Sham_wildtype_12
79 GPL339 GSE5811 GSM135737 C1_CLP_wildtype_8 CLP_wildtype_8
80 GPL339 GSE5811 GSM135738 C3_CLP_wildtype_8 CLP_wildtype_8
81 GPL339 GSE5811 GSM135739 C4_CLP_wildtype_8 CLP_wildtype_8
82 GPL339 GSE5811 GSM135740 C5star_CLP_wildtype_8 CLP_wildtype_8
83 GPL339 GSE5811 GSM135741 C6star_CLP_wildtype_8 CLP_wildtype_8
84 GPL339 GSE5811 GSM135742 S2_Sham_wildtype_8 Sham_wildtype_8
85 GPL339 GSE5811 GSM135743 S3star_Sham_wildtype_8 Sham_wildtype_8
86 GPL339 GSE5811 GSM135744 S4_Sham_wildtype_8 Sham_wildtype_8
87 GPL339 GSE5811 GSM135745 S6_Sham_wildtype_8 Sham_wildtype_8
88 GPL339 GSE7768 GSM188270 Ova, biological replicate 1 Ova
89 GPL339 GSE7768 GSM188271 Ova, biological replicate 2 Ova
90 GPL339 GSE7768 GSM188272 Ova, biological replicate 3 Ova
91 GPL339 GSE7768 GSM188273 OvaLPS, biological replicate 1 OvaLPS
92 GPL339 GSE7768 GSM188274 OvaLPS, biological replicate 2 OvaLPS
93 GPL339 GSE7768 GSM188275 OvaLPS, biological replicate 3 OvaLPS
94 GPL339 GSE7768 GSM188276 OvaMPL, biological replicate 1 OvaMP
95 GPL339 GSE7768 GSM188277 OvaMPL, biological replicate 2 OvaMP
96 GPL339 GSE7768 GSM188278 OvaMPL, biological replicate 3 OvaMP
97 GPL339 GSE3997 GSM91280 B10 TCR double positive rep 1 CD4+CD8+TCRhi
98 GPL339 GSE3997 GSM91281 B10 TCR double positive rep 2 CD4+CD8+TCRhi
99 GPL339 GSE3997 GSM91282 B10 TCR double positive rep 3 CD4+CD8+TCRhi
100 GPL339 GSE3997 GSM91283 NOD TCR double positive rep 1 CD4+CD8+TCRhi
101 GPL339 GSE3997 GSM91284 NOD TCR double positive rep 2 CD4+CD8+TCRhi
102 GPL339 GSE3997 GSM91285 NOD TCR double positive rep 3 CD4+CD8+TCRhi
103 GPL339 GSE3997 GSM91286 B10 Dbl double positive rep 1 CD4+CD8+CD69-TCRlow
104 GPL339 GSE3997 GSM91287 B10 Dbl double positive rep 2 CD4+CD8+CD69-TCRlow
105 GPL339 GSE3997 GSM91288 B10 Dbl double positive rep 3 CD4+CD8+CD69-TCRlow
106 GPL339 GSE3997 GSM91289 NOD Dbl double positive rep 1 CD4+CD8+CD69-TCRlow
107 GPL339 GSE3997 GSM91290 NOD Dbl double positive rep 2 CD4+CD8+CD69-TCRlow
108 GPL339 GSE3997 GSM91291 NOD Dbl double positive rep 3 CD4+CD8+CD69-TCRlow
109 GPL339 GSE2413 GSM45451 0h WT Sample 01 S49 T-lymphoma cell line
110 GPL339 GSE2413 GSM45452 0h WT Sample 13 S49 T-lymphoma cell line
111 GPL339 GSE2413 GSM45453 0h WT Sample 16 S49 T-lymphoma cell line
112 GPL339 GSE2413 GSM45454 0h WT Sample 36 S49 T-lymphoma cell line
113 GPL339 GSE2413 GSM45455 2h WT Cel.02 S49 T-lymphoma cell line
114 GPL339 GSE2413 GSM45456 2h WT Cel.17 S49 T-lymphoma cell line
115 GPL339 GSE2413 GSM45457 2h WT Cel.37 S49 T-lymphoma cell line
116 GPL339 GSE2413 GSM45458 6h WT Cel.03 S49 T-lymphoma cell line
117 GPL339 GSE2413 GSM45459 6h WT Cel.18 S49 T-lymphoma cell line
118 GPL339 GSE2413 GSM45460 6h WT cel.38 S49 T-lymphoma cell line
119 GPL339 GSE2413 GSM45461 24h WT Cel.04 S49 T-lymphoma cell line
120 GPL339 GSE2413 GSM45462 24h WT Cel.19 S49 T-lymphoma cell line
121 GPL339 GSE2413 GSM45463 24h WT Cel.39 S49 T-lymphoma cell line
122 GPL339 GSE2413 GSM45464 0h Kin Cel.05 S49 T-lymphoma cell line
123 GPL339 GSE2413 GSM45465 0h Kin Cel.14 S49 T-lymphoma cell line
124 GPL339 GSE2413 GSM45466 0h Kin Cel.40 S49 T-lymphoma cell line
125 GPL339 GSE2413 GSM45467 0h Kin Cel.44 S49 T-lymphoma cell line
126 GPL339 GSE2413 GSM45468 2h Kin Cel.06 S49 T-lymphoma cell line
127 GPL339 GSE2413 GSM45469 2h Kin- Cel.41 S49 T-lymphoma cell line
128 GPL339 GSE2413 GSM45470 2h Kin- Cel.45 S49 T-lymphoma cell line
129 GPL339 GSE2413 GSM45471 6h kin- Cel.07 S49 T-lymphoma cell line
130 GPL339 GSE2413 GSM45472 6h Kin- Cel.42 S49 T-lymphoma cell line
131 GPL339 GSE2413 GSM45473 6h Kin- Cel.46 S49 T-lymphoma cell line
132 GPL339 GSE2413 GSM45474 24h kin- Cel.08 S49 T-lymphoma cell line
133 GPL339 GSE2413 GSM45475 24h Kin- Cel.43 S49 T-lymphoma cell line
134 GPL339 GSE2413 GSM45476 24h Kin Cel.47 S49 T-lymphoma cell line
135 GPL339 GSE9727 GSM245893 S49_untreated_time0,rep1 S49 T-lymphoma cell line
136 GPL339 GSE9727 GSM245894 S49_untreated_time0,rep2 S49 T-lymphoma cell line
137 GPL339 GSE9727 GSM245895 S49_untreated_time0,rep3 S49 T-lymphoma cell line
138 GPL339 GSE9727 GSM245896 S49_untreated_time0,rep4 S49 T-lymphoma cell line
139 GPL339 GSE9727 GSM245897 S49_treated_2h,rep1 S49 T-lymphoma cell line
140 GPL339 GSE9727 GSM245898 S49_treated_2h,rep2 S49 T-lymphoma cell line
141 GPL339 GSE9727 GSM245899 S49_treated_2h,rep3 S49 T-lymphoma cell line
142 GPL339 GSE9727 GSM245900 S49_treated_6h,rep1 S49 T-lymphoma cell line
143 GPL339 GSE9727 GSM245901 S49_treated_6h,rep2 S49 T-lymphoma cell line
144 GPL339 GSE9727 GSM245902 S49_treated_6h,rep3 S49 T-lymphoma cell line
145 GPL339 GSE9727 GSM245903 S49_treated_24h,rep1 S49 T-lymphoma cell line
146 GPL339 GSE9727 GSM245904 S49_treated_24h,rep2 S49 T-lymphoma cell line
147 GPL339 GSE9727 GSM245905 S49_treated_24h,rep3 S49 T-lymphoma cell line
148 GPL339 GSE9727 GSM248218 S49_untreated_time0,rep1 S49 T-lymphoma cell line
149 GPL339 GSE9727 GSM248219 S49_untreated_time0,rep2 S49 T-lymphoma cell line
150 GPL339 GSE9727 GSM248220 S49_untreated_time0,rep3 S49 T-lymphoma cell line
151 GPL339 GSE9727 GSM248221 S49_untreated_time0,rep4 S49 T-lymphoma cell line
152 GPL339 GSE9727 GSM248222 S49_untreated_2h,rep1 S49 T-lymphoma cell line
153 GPL339 GSE9727 GSM248223 S49_untreated_2h,rep2 S49 T-lymphoma cell line
154 GPL339 GSE9727 GSM248224 S49_untreated_2h,rep3 S49 T-lymphoma cell line
155 GPL339 GSE9727 GSM248225 S49_untreated_6h,rep1 S49 T-lymphoma cell line
156 GPL339 GSE9727 GSM248226 S49_untreated_6h,rep2 S49 T-lymphoma cell line
157 GPL339 GSE9727 GSM248227 S49_untreated_6h,rep3 S49 T-lymphoma cell line
158 GPL339 GSE9727 GSM248228 S49_untreated_24h,rep1 S49 T-lymphoma cell line
159 GPL339 GSE9727 GSM248229 S49_untreated_24h,rep2 S49 T-lymphoma cell line
160 GPL339 GSE9727 GSM248230 S49_untreated_24h,rep3 S49 T-lymphoma cell line
161 GPL1261 GSE15324 GSM384857 WT1 naive CD8 T cells WT naive CD8 T cells N
162 GPL1261 GSE15324 GSM384858 WT2 naive CD8 T cells WT naive CD8 T cells N
163 GPL1261 GSE15324 GSM384859 WT1 activated CD8 T cells WT activated CD8 T cells E
164 GPL1261 GSE15324 GSM384866 WT2 activated CD8 T cells WT activated CD8 T cells E
165 GPL1261 GSE15324 GSM384867 Elf4 KO1 naive CD8 T cells Elf4 KO naive CD8 T cells N
166 GPL1261 GSE15324 GSM384868 Elf4 KO2 naive CD8 T cells Elf4 KO naive CD8 T cells N
167 GPL1261 GSE15324 GSM384869 Elf4 KO1 activated CD8 T cells Elf4 KO activated CD8 T cells E
168 GPL1261 GSE15324 GSM384906 Elf4 KO2 activated CD8 T cells Elf4 KO activated CD8 T cells E
169 GPL1261 GSE6084 GSM140919 T-cell_Cycloheximide_30min_rep1 T cell_Cycloheximide_30min
170 GPL1261 GSE6084 GSM140920 T-cell_Cycloheximide_30min_rep2 T cell_Cycloheximide_30min
171 GPL1261 GSE6084 GSM140921 T-cell_Cycloheximide_30min_rep3 T cell_Cycloheximide_30min
172 GPL1261 GSE6084 GSM140922 T-cell_Cycloheximide_30min_rep4 T cell_Cycloheximide_30min
173 GPL1261 GSE6084 GSM108343 T-cell_IL-2_Cycloheximide_4 hour_rep1 T cell_IL-2_Cycloheximide_4 hour
174 GPL1261 GSE6084 GSM108344 T-cell_IL-2_Cycloheximide_4 hour_rep2 T cell_IL-2_Cycloheximide_4 hour
175 GPL1261 GSE6084 GSM108345 T-cell_IL-2_Cycloheximide_4 hour_rep3 T cell_IL-2_Cycloheximide_4 hour
176 GPL1261 GSE6084 GSM108346 T-cell_IL-2_Cycloheximide_4 hour_rep4 T cell_IL-2_Cycloheximide_4 hour
177 GPL1261 GSE6084 GSM183635 T-cell_Cycloheximide_4.5h_rep1 T cell_Cycloheximide_4.5h
178 GPL1261 GSE6084 GSM183636 T-cell_Cycloheximide_4.5h_rep2 T cell_Cycloheximide_4.5h
179 GPL1261 GSE6084 GSM183637 T-cell_Cycloheximide_4.5h_rep3 T cell_Cycloheximide_4.5h
180 GPL1261 GSE6084 GSM183638 T-cell_Cycloheximide_4.5h_rep4 T cell_Cycloheximide_4.5h
181 GPL1261 GSE11677 GSM296650 CD8 memory T cell_Expansion_rep1 CD8 memory T cell_Expansion M
182 GPL1261 GSE11677 GSM296652 CD8 memory T cell_Expansion_rep2 CD8 memory T cell_Expansion M
183 GPL1261 GSE11677 GSM296654 CD8 memory T cell_Expansion_rep3 CD8 memory T cell_Expansion M
184 GPL1261 GSE11677 GSM296656 CD8 memory T cell_Expansion_rep4 CD8 memory T cell_Expansion M
185 GPL1261 GSE11677 GSM296651 CD8 memory T cell_PolyclonalAged_rep1 CD8 memory T cell_PolyclonalAged M
186 GPL1261 GSE11677 GSM296653 CD8 memory T cell_PolyclonalAged_rep2 CD8 memory T cell_PolyclonalAged M
187 GPL1261 GSE11677 GSM296655 CD8 memory T cell_PolyclonalAged_rep3 CD8 memory T cell_PolyclonalAged M
188 GPL1261 GSE11677 GSM296657 CD8 memory T cell_PolyclonalAged_rep4 CD8 memory T cell_PolyclonalAged M
189 GPL1261 GSE12388 GSM310897 Spleen Aire-wild-type A Spleen Aire-wild-type
190 GPL1261 GSE12388 GSM310900 Spleen Aire-wild-type B Spleen Aire-wild-type
191 GPL1261 GSE12388 GSM310898 Spleen Aire-knockout A Spleen Aire-knockout
192 GPL1261 GSE12388 GSM310901 Spleen Aire-knockout B Spleen Aire-knockout
193 GPL1261 GSE12388 GSM310903 Lymph node Aire-wild-type A Lymph node Aire-wild-type
194 GPL1261 GSE12388 GSM310899 Lymph node Aire-wild-type B Lymph node Aire-wild-type
195 GPL1261 GSE12388 GSM310904 Lymph node Aire-knockout A Lymph node Aire-knockout
196 GPL1261 GSE12388 GSM310902 Lymph node Aire-knockout B Lymph node Aire-knockout
197 GPL1261 GSE11884 GSM300153 Naive_Furin_Wild-type_1 Naive_Furin_Wild-type_1
198 GPL1261 GSE11884 GSM300154 Naive_Furin_Wild-type_2 Naive_Furin_Wild-type_1
199 GPL1261 GSE11884 GSM300155 Naive_Furin_Knockout_1 Naive_Furin_Knockout_1
200 GPL1261 GSE11884 GSM300156 Naive_Furin_Knockout_2 Naive_Furin_Knockout_1
201 GPL1261 GSE11446 GSM288809 CD8 T cells_IL-2 complex treatment_0 h CD8 T cells_IL-2 complex treatment_0 h N
202 GPL1261 GSE11446 GSM288810 CD8 T cells_IL-2 complex treatment_1 h CD8 T cells_IL-2 complex treatment_1 h N
203 GPL1261 GSE11446 GSM288811 CD8 T cells_IL-2 complex treatment_3 h CD8 T cells_IL-2 complex treatment_3 h N
204 GPL1261 GSE10239 GSM257826 CD8 P14 Naive cells-1 CD8 P14 Naive cells N
205 GPL1261 GSE10239 GSM257827 CD8 P14 Naive cells-2 CD8 P14 Naive cells N
206 GPL1261 GSE10239 GSM257828 CD8 P14 Naive cells-3 CD8 P14 Naive cells N
207 GPL1261 GSE10239 GSM257829 CD8 P14 Memory cells-1 CD8 P14 Memory cells M
208 GPL1261 GSE10239 GSM257830 CD8 P14 Memory cells-2 CD8 P14 Memory cells M
209 GPL1261 GSE10239 GSM257831 CD8 P14 Memory cells-3 CD8 P14 Memory cells M
210 GPL1261 GSE10239 GSM257832 CD8 P14 day 4.5 post-infection KLRG-1 Int sorted cells-1 CD8 P14 day4.5pi KLRG-1 Int sorted cells E
211 GPL1261 GSE10239 GSM257833 CD8 P14 day 4.5 post-infection KLRG-1 Int sorted cells-2 CD8 P14 day4.5pi KLRG-1 Int sorted cells E
212 GPL1261 GSE10239 GSM257834 CD8 P14 day 4.5 post-infection KLRG-1 Int sorted cells-3 CD8 P14 day4.5pi KLRG-1 Int sorted cells E
213 GPL1261 GSE10239 GSM257835 CD8 P14 day 4.5 post-infection KLRG-1 Hi sorted cells-1 CD8 P14 day4.5pi KLRG-1 Hi sorted cells E
214 GPL1261 GSE10239 GSM257836 CD8 P14 day 4.5 post-infection KLRG-1 Hi sorted cells-2 CD8 P14 day4.5pi KLRG-1 Hi sorted cells E
215 GPL1261 GSE10239 GSM257837 CD8 P14 day 4.5 post-infection KLRG-1 Hi sorted cells-3 CD8 P14 day4.5pi KLRG-1 Hi sorted cells E
216 GPL1261 GSE9997 GSM252716 Naive_CD8+_T_cells Naive_CD8+_T_cells N
217 GPL1261 GSE9997 GSM252717 Activated_CD8+_T_cells Activated_CD8+_T_cells E
218 GPL1261 GSE6085 GSM108334 T-cell_IL-2_0hour_rep1 cytotoxic T cell_IL-2_0hour
219 GPL1261 GSE6085 GSM108335 T-cell_IL-2_0hour_rep2 cytotoxic T cell_IL-2_0hour
220 GPL1261 GSE6085 GSM108336 T-cell_IL-2_0hour_rep3 cytotoxic T cell_IL-2_0hour
221 GPL1261 GSE6085 GSM108337 T-cell_IL-2_0hour_rep4 cytotoxic T cell_IL-2_0hour
222 GPL1261 GSE6085 GSM108338 T-cell_IL-2_0hour_rep5 cytotoxic T cell_IL-2_0hour
223 GPL1261 GSE6085 GSM183455 T-cell_No IL-2_4 hour_rep1 cytotoxic T cell_No IL-2_4 hour
224 GPL1261 GSE6085 GSM183456 T-cell_No IL-2_4 hour_rep2 cytotoxic T cell_No IL-2_4 hour
225 GPL1261 GSE6085 GSM183457 T-cell_No IL-2_4 hour_rep3 cytotoxic T cell_No IL-2_4 hour
226 GPL1261 GSE6085 GSM183458 T-cell_No IL-2_4 hour_rep4 cytotoxic T cell_No IL-2_4 hour
227 GPL1261 GSE6085 GSM183459 T-cell_No IL-2_8 hour_rep1 cytotoxic T cell_No IL-2_8 hour
228 GPL1261 GSE6085 GSM183460 T-cell_No IL-2_8 hour_rep2 cytotoxic T cell_No IL-2_8 hour
229 GPL1261 GSE6085 GSM183461 T-cell_No IL-2_8 hour_rep3 cytotoxic T cell_No IL-2_8 hour
230 GPL1261 GSE6085 GSM140923 T-cell_IL-2_0.5 hour_rep1 cytotoxic T cell_IL-2_0.5 hour
231 GPL1261 GSE6085 GSM140924 T-cell_IL-2_0.5 hour_rep2 cytotoxic T cell_IL-2_0.5 hour
232 GPL1261 GSE6085 GSM140925 T-cell_IL-2_0.5 hour_rep3 cytotoxic T cell_IL-2_0.5 hour
233 GPL1261 GSE6085 GSM140926 T-cell_IL-2_1 hour_rep1 cytotoxic T cell_IL-2_1 hour
234 GPL1261 GSE6085 GSM140927 T-cell_IL-2_1 hour_rep2 cytotoxic T cell_IL-2_1 hour
235 GPL1261 GSE6085 GSM140928 T-cell_IL-2_1 hour_rep3 cytotoxic T cell_IL-2_1 hour
236 GPL1261 GSE6085 GSM140929 T-cell_IL-2_2 hour_rep1 cytotoxic T cell_IL-2_2 hour
237 GPL1261 GSE6085 GSM140930 T-cell_IL-2_2 hour_rep2 cytotoxic T cell_IL-2_2 hour
238 GPL1261 GSE6085 GSM140931 T-cell_IL-2_2 hour_rep3 cytotoxic T cell_IL-2_2 hour
239 GPL1261 GSE6085 GSM108339 T-cell_IL-2_4 hour_rep1 cytotoxic T cell_IL-2_4 hour
240 GPL1261 GSE6085 GSM108340 T-cell_IL-2_4 hour_rep2 cytotoxic T cell_IL-2_4 hour
241 GPL1261 GSE6085 GSM108341 T-cell_IL-2_4 hour_rep3 cytotoxic T cell_IL-2_4 hour
242 GPL1261 GSE6085 GSM108342 T-cell_IL-2_4 hour_rep4 cytotoxic T cell_IL-2_4 hour
243 GPL1261 GSE6085 GSM140932 T-cell_IL-2_6 hour_rep1 cytotoxic T cell_IL-2_6 hour
244 GPL1261 GSE6085 GSM140933 T-cell_IL-2_6 hour_rep2 cytotoxic T cell_IL-2_6 hour
245 GPL1261 GSE6085 GSM140934 T-cell_IL-2_6 hour_rep3 cytotoxic T cell_IL-2_6 hour
246 GPL1261 GSE6085 GSM140935 T-cell_IL-2_8 hour_rep1 cytotoxic T cell_IL-2_8 hour
247 GPL1261 GSE6085 GSM140936 T-cell_IL-2_8 hour_rep2 cytotoxic T cell_IL-2_8 hour
248 GPL1261 GSE6085 GSM140937 T-cell_IL-2_8 hour_rep3 cytotoxic T cell_IL-2_8 hour
249 GPL1261 GSE6085 GSM140938 T-cell_IL-2_10 hour_rep1 cytotoxic T cell_IL-2_10 hour
250 GPL1261 GSE6085 GSM140939 T-cell_IL-2_10 hour_rep2 cytotoxic T cell_IL-2_10 hour
251 GPL1261 GSE6085 GSM140940 T-cell_IL-2_10 hour_rep3 cytotoxic T cell_IL-2_10 hour
252 GPL1261 GSE6085 GSM140941 T-cell_IL-2_12 hour_rep1 cytotoxic T cell_IL-2_12 hour
253 GPL1261 GSE6085 GSM140942 T-cell_IL-2_12 hour_rep2 cytotoxic T cell_IL-2_12 hour
254 GPL1261 GSE6085 GSM140943 T-cell_IL-2_12 hour_rep3 cytotoxic T cell_IL-2_12 hour
255 GPL1261 GSE6085 GSM140944 T-cell_IL-2_16 hour_rep1 cytotoxic T cell_IL-2_16 hour
256 GPL1261 GSE6085 GSM140945 T-cell_IL-2_16 hour_rep2 cytotoxic T cell_IL-2_16 hour
257 GPL1261 GSE6085 GSM140946 T-cell_IL-2_16 hour_rep3 cytotoxic T cell_IL-2_16 hour
258 GPL1261 GSE6085 GSM140947 T-cell_IL-2_24 hour_rep1 cytotoxic T cell_IL-2_24 hour
259 GPL1261 GSE6085 GSM140948 T-cell_IL-2_24 hour_rep2 cytotoxic T cell_IL-2_24 hour
260 GPL1261 GSE6085 GSM140949 T-cell_IL-2_24 hour_rep3 cytotoxic T cell_IL-2_24 hour
261 GPL1261 GSE8039 GSM198411 C1 peripheral lymph node peripheral lymph node
262 GPL1261 GSE8039 GSM198412 C2 peripheral lymph node peripheral lymph node
263 GPL1261 GSE8039 GSM198413 C3 peripheral lymph node peripheral lymph node
264 GPL1261 GSE8039 GSM198414 C4 peripheral lymph node peripheral lymph node
265 GPL1261 GSE8039 GSM198409 T1 CD2-CD30L peripheral lymph node CD2-CD30L peripheral lymph node
266 GPL1261 GSE8039 GSM198410 T2 CD2-CD30L peripheral lymph node CD2-CD30L peripheral lymph node
267 GPL1261 GSE8039 GSM198415 T3 CD2-CD30L peripheral lymph node CD2-CD30L peripheral lymph node
268 GPL1261 GSE8039 GSM198416 T4 CD2-CD30L peripheral lymph node CD2-CD30L peripheral lymph node
269 GPL1261 GSE8039 GSM198423 C1 mesenteric lymph node mesenteric lymph node
270 GPL1261 GSE8039 GSM198424 C2 mesenteric lymph node mesenteric lymph node
271 GPL1261 GSE8039 GSM198417 C3 mesenteric lymph node mesenteric lymph node
272 GPL1261 GSE8039 GSM198418 C4 mesenteric lymph node mesenteric lymph node
273 GPL1261 GSE8039 GSM198419 T3 mesenteric lymph node mesenteric lymph node
274 GPL1261 GSE8039 GSM198420 T4 mesenteric lymph node mesenteric lymph node
275 GPL1261 GSE8039 GSM198421 T1 CD2-CD30L mesenteric lymph node CD2-CD30L mesenteric lymph node
276 GPL1261 GSE8039 GSM198422 T2 CD2-CD30L mesenteric lymph node CD2-CD30L mesenteric lymph node
277 GPL1261 GSE8039 GSM198427 C1 spleen spleen
278 GPL1261 GSE8039 GSM198428 C2 spleen spleen
279 GPL1261 GSE8039 GSM198431 C3 spleen spleen
280 GPL1261 GSE8039 GSM198432 C4 spleen spleen
281 GPL1261 GSE8039 GSM198425 T1 CD2-CD30L spleen CD2-CD30L spleen
282 GPL1261 GSE8039 GSM198426 T2 CD2-CD30L spleen CD2-CD30L spleen
283 GPL1261 GSE8039 GSM198429 T3 CD2-CD30L spleen CD2-CD30L spleen
284 GPL1261 GSE8039 GSM198430 T4 CD2-CD30L spleen CD2-CD30L spleen
285 GPL1261 GSE8039 GSM198439 C1 Thymus Thymus
286 GPL1261 GSE8039 GSM198440 C2 Thymus Thymus
287 GPL1261 GSE8039 GSM198433 C3 Thymus Thymus
288 GPL1261 GSE8039 GSM198434 C4 Thymus Thymus
289 GPL1261 GSE8039 GSM198437 T1 CD2-CD30L Thymus CD2-CD30L Thymus
290 GPL1261 GSE8039 GSM198438 T2 CD2-CD30L Thymus CD2-CD30L Thymus
291 GPL1261 GSE8039 GSM198435 T3 CD2-CD30L Thymus CD2-CD30L Thymus
292 GPL1261 GSE8039 GSM198436 T4 CD2-CD30L Thymus CD2-CD30L Thymus
293 GPL1261 GSE8678 GSM215223 Effector CD8 T cells, IL-7Rlo, rep1 Effector CD8 T cells, IL-7Rlo E
294 GPL1261 GSE8678 GSM215224 Effector CD8 T cells, IL-7Rlo, rep2 Effector CD8 T cells, IL-7Rlo E
295 GPL1261 GSE8678 GSM215225 Effector CD8 T cells, IL-7Rlo, rep3 Effector CD8 T cells, IL-7Rlo E
296 GPL1261 GSE8678 GSM215226 Effector CD8 T cells, IL-7Rhi, rep1 Effector CD8 T cells, IL-7Rhi MP
297 GPL1261 GSE8678 GSM215227 Effector CD8 T cells, IL-7Rhi, rep2 Effector CD8 T cells, IL-7Rhi MP
298 GPL1261 GSE8678 GSM215228 Effector CD8 T cells, IL-7Rhi, rep3 Effector CD8 T cells, IL-7Rhi MP
299 GPL1261 GSE2924 GSM62977 CD8+Tet-_04 CD8+Tet- E
300 GPL1261 GSE2924 GSM62978 CD8+Tet-_02 CD8+Tet- E
301 GPL1261 GSE2924 GSM62979 CD8+Tet-_03 CD8+Tet- E
302 GPL1261 GSE2924 GSM62980 CD8+Tet-_01 CD8+Tet- E
303 GPL1261 GSE2924 GSM62981 CD8+Tet-_05 CD8+Tet- E
304 GPL1261 GSE2924 GSM62982 CD8+HYTet+_01 CD8+HYTet+ E
305 GPL1261 GSE2924 GSM62983 CD8+HYTet+_02 CD8+HYTet+ E
306 GPL1261 GSE2924 GSM62984 CD8+HYTet+_03 CD8+HYTet+ E
307 GPL1261 GSE2924 GSM62985 CD8+HYTet+_04 CD8+HYTet+ E
308 GPL1261 GSE2924 GSM62986 CD8+H7aTet+_01 CD8+H7aTet+ E
309 GPL1261 GSE2924 GSM62987 CD8+H7aTet+_02 CD8+H7aTet+ E
310 GPL1261 GSE2924 GSM62988 CD8+H7aTet+_03 CD8+H7aTet+ E
311 GPL1261 GSE2924 GSM62876 CD8+H7aTet+_04 CD8+H7aTet+ E
312 GPL1261 GSE13493 GSM340091 DP thymocytes 1 CD4+CD8+ thymocytes
313 GPL1261 GSE13493 GSM340092 DP thymocytes 2 CD4+CD8+ thymocytes
314 GPL1261 GSE13493 GSM340093 CD4intCD8+ thymocytes 1 CD4intCD8+ thymocytes
315 GPL1261 GSE13493 GSM340094 CD4intCD8+ thymocytes 2 CD4intCD8+ thymocytes
316 GPL1261 GSE13493 GSM340095 CD8SP thymocytes 1 CD8SP thymocytes N
317 GPL1261 GSE13493 GSM340096 CD8SP thymocytes 2 CD8SP thymocytes N
318 GPL1261 GSE10813 GSM273000 Fresh CD8 rep1 Fresh CD8 N
319 GPL1261 GSE10813 GSM273001 Fresh CD8 rep2 Fresh CD8 N
320 GPL1261 GSE10813 GSM273005 Stimulated CD8 rep1 Stimulated CD8 E
321 GPL1261 GSE10813 GSM273006 Stimulated CD8 rep2 Stimulated CD8 E
322 GPL1261 GSE10813 GSM273002 Expanded CD8 Tcells with Suppression function rep2 Expanded CD8 Tcells with suppression function
323 GPL1261 GSE10813 GSM272995 Expanded CD8 Tcells with Suppression function rep1 Expanded CD8 Tcells with suppression function
324 GPL1261 GSE10813 GSM272996 Expanded CD8 Tcells with Suppression function rep3 Expanded CD8 Tcells with suppression function
325 GPL1261 GSE10813 GSM272997 Expanded CD8 Tcells with Suppression function rep4 Expanded CD8 Tcells with suppression function
326 GPL1261 GSE10813 GSM272998 Expanded CD8 Tcells with Suppression function rep5 Expanded CD8 Tcells with suppression function
327 GPL1261 GSE14699 GSM366905 OT-I_T_cell_Naive_rep1 OT-I_T_cell_Naive N
328 GPL1261 GSE14699 GSM366912 OT-I_T_cell_Naive_rep2 OT-I_T_cell_Naive N
329 GPL1261 GSE14699 GSM366911 OT-I_T_cell_Rag_rep1 OT-I_T_cell_Rag N
330 GPL1261 GSE14699 GSM366907 OT-I_T_cell_RIP-OVAhi_rep1 OT-I_T_cell_RIP-OVAhi
331 GPL1261 GSE14699 GSM366914 OT-I_T_cell_RIP-OVAhi_rep2 OT-I_T_cell_RIP-OVAhi
332 GPL1261 GSE14699 GSM366909 OT-I_T_cell_OCS/LPS_rep1 OT-I_T_cell_OCS/LPS E
333 GPL1261 GSE14699 GSM366916 OT-I_T_cell_OCS/LPS_rep2 OT-I_T_cell_OCS/LPS E
334 GPL1261 GSE4178 GSM95588 NK1.1 minus TGFbeta RII KO T cells T_KO NK1.1- TGFbeta RII KO T cells T_KO N
335 GPL1261 GSE4178 GSM95589 NK1.1 minus control T cells T_WT NK1.1- control T cells T_WT N
336 GPL1261 GSE6810 GSM155205 Control replicate 1 Control
337 GPL1261 GSE6810 GSM155248 Control replicate 2 Control
338 GPL1261 GSE6810 GSM155249 B. abortus 2308 replicate 1 B. abortus 2308
339 GPL1261 GSE6810 GSM155251 B. abortus 2308 replicate 2 B. abortus 2308
340 GPL1261 GSE6810 GSM155252 B. abortus BA41 replicate 1 B. abortus BA41
341 GPL1261 GSE6810 GSM155253 B. abortus 2308 BA41 replicate 2 B. abortus BA41
342 GPL1261 GSE6810 GSM155254 B. abortus 2308 ADH4.2 replicate 1 B. abortus 2308 ADH4.2
343 GPL1261 GSE6810 GSM155255 B. abortus 2308 ADH4.2 replicate 2 B. abortus 2308 ADH4.2
344 GPL1261 GSE6810 GSM155256 B. melitensis 16M replicate 1 B. melitensis 16M
345 GPL1261 GSE6810 GSM155257 B. melitensis 16M replicate 2 B. melitensis 16M
346 GPL1261 GSE15037 GSM375666 Wild-type CD8 T cell Wild-type CD8 T cell N
347 GPL1261 GSE15037 GSM375667 Foxo1KO CD8 T cell Foxo1KO CD8 T cell N
348 GPL1261 GSE1566 GSM26964 LNT-1 LN T cells-WT N
349 GPL1261 GSE1566 GSM26965 LNT-2 LN T cells-WT N
350 GPL1261 GSE1566 GSM26966 LN-T-3 LN T cells-WT N
351 GPL1261 GSE1566 GSM26967 LNT-4 LN T cells-Ezh2 KO N
352 GPL1261 GSE1566 GSM26968 LNT-5 LN T cells-Ezh2 KO N
353 GPL1261 GSE1566 GSM26969 LNT-6 LN T cells-Ezh2 KO N
354 GPL1261 GSE7694 GSM186666 C57BL/6J female number 1, untreated control ear (#1_Wt-C-3) cutaneous T cell
355 GPL1261 GSE7694 GSM186667 C57BL/6J female number 2, untreated control ear (#2_Wt-C-4) cutaneous T cell
356 GPL1261 GSE7694 GSM186668 C57BL/6J female number 3, untreated control ear (#3_Wt-C-7) cutaneous T cell
357 GPL1261 GSE7694 GSM186709 C57BL/6J female number 1, DNFB-treated allergic ear (#4_Wt-Tr-3) cutaneous T cell
358 GPL1261 GSE7694 GSM186710 C57BL/6J female number 2, DNFB-treated allergic ear (#5_Wt-Tr-4) cutaneous T cell
359 GPL1261 GSE7694 GSM186711 C57BL/6J female number 3, DNFB-treated allergic ear (#6_Wt-Tr-7) cutaneous T cell
360 GPL1261 GSE7694 GSM186743 Cnr1-/-/Cnr2-/- female number 1, untreated control ear (#7_Ko-C-4) cutaneous T cell
361 GPL1261 GSE7694 GSM187134 Cnr1-/-/Cnr2-/- female number 2, untreated control ear (#8_Ko-C-5) cutaneous T cell
362 GPL1261 GSE7694 GSM187135 Cnr1-/-/Cnr2-/- female number 3, untreated control ear (#9_Ko-C-7) cutaneous T cell
363 GPL1261 GSE7694 GSM187136 Cnr1-/-/Cnr2-/- female number 1, DNFB-treated allergic ear (#10_Ko-Tr-4) cutaneous T cell
364 GPL1261 GSE7694 GSM187137 Cnr1-/-/Cnr2-/- female number 2, DNFB-treated allergic ear (#11_Ko-Tr-5) cutaneous T cell
365 GPL1261 GSE7694 GSM187138 Cnr1-/-/Cnr2-/- female number 3, DNFB-treated allergic ear (#12_Ko-Tr-7) cutaneous T cell
366 GPL1261 GSE6506 GSM149585 CD8+ naive T-cells t8n_1 CD8+ T-cells N
367 GPL1261 GSE6506 GSM149586 CD8+ naive T-cells t8n_2 CD8+ T-cells N
368 GPL1261 GSE6506 GSM149589 CD8+ activated T-cells t8a_1 CD8+ T-cells E
369 GPL1261 GSE6506 GSM149590 CD8+ activated T-cells t8a_2 CD8+ T-cells E
370 GPL1261 GSE7050 GSM161520 thymus_control1 thymus
371 GPL1261 GSE7050 GSM161521 thymus_control2 thymus
372 GPL1261 GSE7050 GSM161526 thymus_control3 thymus
373 GPL1261 GSE7050 GSM161527 thymus_control4 thymus
374 GPL1261 GSE7050 GSM161528 thymus_control5 thymus
375 GPL1261 GSE7050 GSM161522 thymus_lymphoma1 thymus
376 GPL1261 GSE7050 GSM161523 thymus_lymphoma2 thymus
377 GPL1261 GSE7050 GSM161514 thymus_lymphoma3 thymus
378 GPL1261 GSE7050 GSM161515 thymus_lymphoma4 thymus
379 GPL1261 GSE7050 GSM161516 thymus_lymphoma5 thymus
380 GPL1261 GSE7050 GSM161517 thymus_lymphoma6 thymus
381 GPL1261 GSE7050 GSM161518 thymus_lymphoma7 thymus
382 GPL1261 GSE7050 GSM161519 thymus_lymphoma8 thymus
383 GPL1261 GSE12581 GSM315613 T-cell control sample T cell
384 GPL1261 GSE12581 GSM315600 T-cell sample 1 T-Cell leukemia
385 GPL1261 GSE12581 GSM315601 T-cell sample 2 T-Cell leukemia
386 GPL1261 GSE12581 GSM315602 T-cell sample 3 T-Cell leukemia
* collected till Sept 2009
** Classification: N, naïve; E,effector; M, memory;MP,memory precursor
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Klf2RRT $#$$"""#!"#!"!!""$!"
Eomes_1504 GTCAACACTTTGCCTCAAGC
Emoes_1862 AAGACAGGTGGGCTCATTCT
Tbx21_817 GAGGTGAATGATGGAGAGCC
Tbx21_1183 CATAACTGTGTTCCCGAGGT
Bhlh40_152 AAACTTACAAACTGCCGCAC
Bhlh40_502 ATTTCAGGTCCCGAGTGTTC
Id2_92 !$$$"!#"!"#$#"$#$#!$
Id2_336 "!#"$#"!#"#$$"#"##$!
Id3_107 !"$$#$##!"$$#$##""!$
Id3_235 CGAGGATGTAGTCTATGACACG
Prdm1_1227 "!!#"###$$#!#""##$$"
Prdm1_1447 ""!""##!$#"#!"!$"""!#
Bach2_1076 $#$!"$!!$$$##!"#$!""
Bach2_1353 "$#$!$$"$!"!"#!#"!!#
Runx2_1409 CAGCCACCTTTACCTACACC
Runx2_1711 CGTCAACACCATCATTCTGG
Stat4_1063 #!#$!""#"!!!"#!!!""$"
Stat4_1443 !!$$!!"##$#"""!"#$"
Supplementary Table S6. Primers for ChIP-PCR.
Pimer sequence disance to TSS (bp)
Hprt_603 GCCTTGAACTCAGAAATCCG -397
Hprt_806 CCCAGATAATCACTCCGCA -194
Gapdh_738 CCTATCAGTTCGGAGCCCA -262
Gapdh_902 GCCCTGCTTATCCAGTCCTA -98
Sox4_915 GAAGCGTTAGTTACAGCGGC -85
Sox4_1136 TGTTTCTCCCTCCCTCCTG 136
Tcf7_692 GCCCAGGTGACTGACTAATCC -308
Tcf7_876 ACTTGACAGGGAACAGCGAC -124
Eomes_604 ACCAGGATTGATTCTCAGTGG -396
Eomes_857 GACCGCTTGGAAACTTGTG -143
Tbx21_519 GACAAGAGACAGCGAGCAAAC -481
Tbx21_777 AATCTGGGAAAGAGTCAACCTG -223
Prdm1_182 GGATGTCCTTCCTTCTCCAGA -818
Prdm1_509 GGATTTCATTTCTCCTGCTAACTG -491
Klf2_566 CAAAGATTTCACAGAGCGTTCC -434
Klf2_760 AACAAACCAGGCACAACAGC -240
Bach2a_79 GCTGTGGAAACTCAGTGGAAG -921
Bach2a_364 TTCATCAAAGGGAAAGCCG -636
Bhlhe40_744 AGTGTTCGTGGAAGTGACCG -256
Bhlhe40_951 GCTACAACCAATCAGCGGG -49
Id2_630 GTCTGCTGTGCGGAGAGAGT -370
Id2_848 AGCCAATGCCTGTAGGGTG -152
Id3_834 CAGACCAGCCTAAGGAAGCC -166
Id3_1026 GAGACACCTAAAGCAGCAAACA 26
Runx2_883 GGCAGTCCCACTTTACTTTGAG -117
Runx2_1087 AAACGCCAGAGCCTTCTTG 87
Gzmb_707 CAAGAGATGAGCCCAAATGC -293
Gzmb_889 GAACCCACAGCGAATGACTC -111
Sell_810 TGGTCCACTACTGTGTTCTTGG -190
Sell_960 TGCTTTCTTTCATTTCTCCAGC -40
Il7r_813 TGAAGTCTACCACCTTGCTCAA -187
Il7r_1024 CTCTGTGCCTGCTAAACCAC 24
Ccr7_652 CTGCTGGGACAATAGCCACT -348
Ccr7_829 TGTAGAGACTCAGGGAGGAGC -171
Prf1_888 CAGGGCAGGAAGTAGTAATGATATG -112
Prf1_1036 CTTCCTCCTCCTTACCTGAAGTC 36
Ccl5_808 AGGGCAGTTAGAGGCAGAGTC -192
Ccl5_963 CCAGGGTAGCAGAGGAAGTG 37
Gzmk_708 GTGACCCACAGGTTGAGAGC -292
Gzmk_973 ACGGACAAACTGCTTGCTTC -27
Il18r1_638 GTGGTTGAGTAGACAGGCTGC -362
Il18r1_865 GCTTTCAGTTCTGGGAAGACC -135
Il6ra_427 ACACTGGTTTCGTTGCCTC -573
Il6ra_611 GGTGCTTACGGGAATCAAA -389
S100a4_737 TTCCTAAACTTCTGGCTGAGC -263
S100a4_906 TGATGTAGTAAATGTCATAGCACCC -94
S100a6_781 ACCACCACAACTTGAAGAACAG -219
S100a6_936 GGACTGGGAACCACACTGAT -64
Stat4_612 AGAGAAGAATCCAGGTGGCAC -388
Stat4_895 AGACATTGAGGACCAGGCAG -105
Ifng_645 CTGTGCTGTGCTCTGTGGAT -355
Ifng_823 GACTCCTTGGGCTCTCTGAC -177
Cxcr3_557 ATGCCAGGTCTGATTCAACC -443
Cxcr3_857 ACTTGGGACTGTTACAAAGCCT -143
Abca3_497 TTGGTGACAAGAGTGAGATGG -503
Abca3_672 AACAGTAGGCGTTAGTTTGGG -328
Dusp14_595 GCCAACCTGGTCTACATAGTGAG -405
Dusp14_880 CACCTGGACTTACTCGCAGA -120
Blk_801 AGTCCAGTCACATCTGTTCTGC -199
Blk_1002 CCCTTGGTTGGTTTGTTAGG 2
Ms4a1_666 TACCTTCTCAGGGATTCCGAC -334
Ms4a1_913 ACCTTGCTTTGCCTTACCAG -87
Ccr5_779 TTCTGATTTCCAACGAAGTGTG -221
Ccr5_1070 GATGTCTCACCTCCTCTGGC 70
Klrc1_843 TTGTTGTTACCACAGCACTCG -157
Klrc1_1049 AGTTCTTTGCCACCTTCAGTTC 49
Cd38_841 TCTGGAGTCTGGAAGTAAGCAGT -159
Cd38_1017 GAAGAGAGCACAGGGCTGAC 17
